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Summary: 
The Micronucleus (MN) Assay is a test mandated for use in genetic toxicology 
testing by regulatory bodies such as the Food and Drug administration (FDA). An 
increased quantity of MN is an indication of chromosomal damage which can be 
characterised into chromosomal breakage (caused by a clastogen) and chromosomal 
loss (caused by an aneugen). By comparing a dose response, estimates can be made 
into the potency of the chemical. Historically the cell scoring procedure takes place 
through the ‘gold standard’ of manual scoring by light microscopy following 
staining. However, despite being classed the gold standard, this method is laborious 
and subjective, with archiving of results not a possibility.  
This leads to the need to develop a new technique to streamline the process, whilst 
still maintaining accuracy. The result is the creation of a ground truth based deep 
learning algorithm. By using imaging flow cytometry to carry out the MN assay, a 
ground truth was created, consisting of different cellular types, including MN. By 
scoring these images manually by eye, a ground truth of images to teach the deep-
learning algorithm is created.  
By applying a deep neural network, the algorithm uses multiple layers to differentiate 
information, mimicking the way neurons work in the brain. This approach allows for 
differentiation between different cellular types based on the ground truth images 
scored.  By assessing more images, the accuracy is further increased. This is 
advantageous as a MN count is generated directly after processing the imaging flow 
cytometry file. This streamlines the process completely whilst maintaining accuracy. 
Also, by using three different laboratory datasets in the production of the ground 
truth, application was shown to be accurate for cross-laboratory use, a novelty in this 
research setting.  
This allows for the existing ground truth to be used for future MN scoring, allowing 
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1. Literature Review 
 
 
 i) Cell cycle. 
 
The cell cycle is split into 4 main stages, G1, S, G2 and Mitosis (Copper, 2000). 
There is first an increase in cell size, characterised by the G1 stage (Copper, 2000). 
Following this, the cell synthesises new DNA resulting in the S stage. The cell is 
then required to prepare for division in the G2 phase and carry out the division in the 
Mitosis phase. G1, S and G2 are commonly grouped together under the interphase 
stage. Mitosis itself can be further distinguished into 5 main stages: Prophase, 
Prometaphase, Metaphase, Anaphase and Telophase. It is during this replication 
state, where the cell is vulnerable to errors taking place. Each time cellular division 
occurs, replication errors manifest. This can be highlighted via micronucleus (MN) 
formation, when damage to chromosomes causes a smaller MN to be formed during 
Anaphase, though this will be expanded on later (Fenech, 2011). 
 There are 3 mechanisms responsible for S phase replication occurring without fault 
(Kunkel, 2009, Ganai and Johansson, 2016). The first is the: nucleotide 
discrimination of the polymerase activity of the replicative DNA polymerases. The 
second is the: proofreading excision of mismatched primer nucleotides, and 
proofreading excision of mis-incorporated primer nucleotides by the 3’ to 5’ 
exonuclease activity of Pol ε and Pol δ. The third is: post replication mismatch repair 
(MMR) which works in combination with DNA replication in order to spot, excise 
and therefore replace any mismatched nucleotides or recently replicated daughter 
strands which remain (Bui D and Li J, 2019). 
 
 
ii) Cellular damage. 
 
Despite these mechanisms present for ensuring nucleotide integrity, the nucleotide 
error rate still lies at roughly 10-10Bui and Li, 2019). This leaves room for mutation 
and consequently damage to occur. Cells are constantly at threat from sources of 
damage, be it endogenous sources, such as with a DNA mismatch or reactive oxygen 
species (ROS) or exogenous such as: x-rays or cigarette smoke (Chatterjee and 
Walker, 2017). These sources of damage to the cell can cause a great deal of 
genomic instability, which is one of the hallmarks of cancer (Hanahan and Weinberg, 
2011). Moreover, this can cause certain key proteins to mutate, with proteins such as 
p53, known as the ‘guardian of the genome’ mutated and losing function in over 50% 
of human cancers (Lane, 1992 and Barker et al., 1989). Some sources, such as 
radiation can also lead to damage on a chromosomal level and was amongst the first 
discoveries to show that physical agents cause damage and therefore alterations to 
genetic matter (Evans et al., 1977). Moreover, it has been shown that these 
chromosomal abnormalities are of a direct consequence of damage occurring at the 
DNA level with breaks in chromosomes taking place due to double strand breaks in 
the DNA itself and an error in DNA mis-repair leading to chromosome 
rearrangement (Savage, 1993). This chromosomal damage has been shown to be of 
major importance in many diseases with cancers being a leading outcome (Roos et 
al., 2016).  
iii) Cancer 
 
The use of genotoxic compounds and their exposure to the population causes 
chromosomal, DNA and cellular damage to take place as mentioned. This damage 
can result in a somatic mutation when the damage has taken place in a somatic cell. 
This can then result in a transformation of the cell resulting in malignancy (Phillips 
and Arlt, 2009). This theory can be described as the ‘Somatic Mutation Theory’ and 
despite the theory being questionable for most cancers, it remains true that exposure 
to genotoxins is a cause of cancers (Brücher and Jamall, 2016).  
Cancer is an ever-growing problem, in 2018 it was thought that around 1.7 million 
new cases of cancer appeared in the United States, with just over 600,000 of these 
cases resulting in mortality (National Cancer Institute, 2018). By inducing key 
mutations, defence mechanisms are stifled and the cancer is allowed to keep on 
dividing and, in the later stages, metastasise to other areas of the body, causing 
complications and in 163.5 per 100,00 individuals on the whole mortality ( National 
Cancer Institute, 2018). The generic signs of cancers are highlighted in two key 
papers, the Hallmarks of Cancer, and the Hallmarks of Cancer: the next generation 
(Hanahan and Weinberg, 2000 and Hanahan and Weinberg, 2011). The disease has 
many diverse and fatal forms, ranging from liquid cancers targeting the blood such as 
Hodgkin’s lymphoma to brain cancers derived from cells producing the fatty 
covering of the nerves such as an oligodendroglioma.  
That so many distinct forms of cancers exist, merely highlights the significance of 
testing drugs, food, and drinks in order to ensure genotoxins and carcinogens are not 
















1.1 Genetic toxicology. 
 
i) Genotoxicity overview 
 
Genetic toxicology is the study of chemicals ability to directly damage DNA. By 
directly damaging DNA and causing lesions, such genotoxins contribute to cell death 
and mutations which can have a direct link to diseases such as cancers. It is 
important to differentiate mutagenicity and genotoxicity. Mutagens have the ability 
to cause damage to DNA in both direct and indirect forms, whereas genotoxins only 
cause direct damage. All mutagens are therefore genotoxic, but not all genotoxins are 
mutagenic. 
Due to the deleterious effects, highlighted in disease such as cancer, there is the need 
to have precise and accurate tests, both sensitive and specific for assessing such 
genotoxicity. There is the requirement to distinguish the mechanisms by which 
genotoxins or carcinogens may present themselves. Therefore, it is vital to undergo a 
multitude of tests on a substance which is being tested. Therefore, there is a battery 
test system in place. This involves the Ames test and the MN assay as two main test 
systems (OECD, 2013). 
The Ames test is used to distinguish point mutations with the main mutation types 
detected being frame shifts and base substitutions (Mortelmans and Zeiger, 2000). 
The test focuses on using histidine dependent bacteria strains, where a mutation is 
required for viable bacteria to grow. This allows for mutant causing chemicals to be 
distinguished as when added these substances would cause an above normal 
proportion of viable bacteria to form on the plate. As these bacteria would have 
undergone mutations to his+ and thus will be able to grow the colonies (Mortelmans 
and Zeiger, 2000).  
There are other tests used in accordance with the Ames test, including the Comet 
assay which can be used to assess low levels of DNA damage (Olive and Banάth, 
2006). The test in focus, however, is the MN assay which is an OECD approved test 











ii) MN assay. 
 
 
a) Background and Explanation. 
 
The MN test is a standard genotoxic test used to quantify chromosomal damage 
(OECD, 2014). Chromosome damage includes both chromosome breaks and 
chromosome loss. Chromosome loss is caused by aneugenic substances. Clastogenic 
substances cause chromosome breaks. The test is approved by regulatory authorities 
and is a standard test used in chromosomal damage tests (OECD, 2014 and 
ICHS2(R1), 2012). It is of vital importance to fully grasp the importance and 
mechanisms surrounding the MN assay to move onto the techniques used in its 
analysis. 
MN form when entire chromosomes or fragments of the chromosome cannot travel 
to the spindle during mitosis and lag. They are therefore not part of one of the main 
nuclei during division and their nuclear content is covered by their own separate 
nuclear envelope (Fenech, 2000). The phenotypic differences between a normal cell 
and one carrying a MN and the general ease in differentiating the two forms a large 




The MN was initially used as a marker of chromosomal damage over 40 years ago 
(Schmid, 1975 and Heddle, 1973). MN were known to haematologists in dividing 
cell populations such as those found in the bone marrow. Incidentally, the bone 
marrow is one of the OECD testing standards for the MN assay (OECD, 2014).  
The MN assay took over from the more complex and time-consuming approach of 
metaphase aberration counting (Natarajan and Obe, 1982). In this technique, 
chromosomes were studied by spotting and counting aberrations shown during 
metaphase. Despite the detail, the loss of chromosomes during metaphase due to 
preparation methods, compounded with the time-consuming nature and complexities 
led to a simpler method required for chromosomal damage analysis (Fenech, 2000). 
This method was the MN assay. 
 
c) MN mechanism 
 
As mentioned previously, MN are used to detect either clastogenic substances 
through chromosomal breaks or aneugenic substances through chromosomal loss 
(See Fig. 1). This is due to the chromosomal damage disrupting the journey of the 
entire chromosome to the spindle during mitosis. This allows for a nuclear envelope 
to form around some of the DNA in the form of chromosomes and fragments at this 
point. The DNA material unwinds and shares much of the same morphology as a 
normal nucleus during interphase, the main difference being the far smaller size. It is 
also possible for nuclear buds and nucleoplasmic bridges to form at a similar stage, 
however such events are much rarer than MN and can be noted when scoring MN.  
There are two ways of carrying out the assay. The test can be carried out both in vitro 
and in vivo (with the use of animal tissue, primarily liver cells when using chemicals 
requiring oxidation). The in vitro method is becoming a more popular approach in 
the scientific community overall, due to the issues raised ethically with the use of 
animals in scientific experiments. This is also compliant with the 3 R’s principle 
towards animal testing, Replacement, Reduction and Refinement (NC3Rs, 2020).  As 
it is becoming clearer that the use of animals when carrying out in vivo methods is 
slowly becoming outdated and the systems are not in fact as reliable as previously 
thought when compared to the working human environment. Therefore, the 3 R’s 
principle is becoming more prominent in research, with an increased emphasis on 
increasing mechanistic understanding of biological systems in order to replicate this 
in a more accurate in vitro test. It must be noted that 23% of oncology drugs in a late 
stage clinical development review failed due to cytotoxicity reasons (Jardim et al., 
2017).  More of this will be touched upon later, the MN work carried out during this 
project was undertaken in an in vitro setting. 
                                     
Figure. 1 Schematic showing MN formation by chromosomal breakage and chromosomal loss 




It is important to note there are two main forms of MN assay, whether it is carried 
out in an in vitro or in vivo setting. The assay can be carried out using mononucleated 
cells and thus analysing mononucleated cells containing a MN to determine the MN 
frequency. The other type is the binucleated MN assay, where Cytocholasin-B (cyto-
B) is added to form binucleated cells, which are then analysed and thus binucleated 
MN cells are analysed to obtain a MN frequency (See Fig. 2).  
Cyto-B is a mycotoxin permeable to the cellular membrane which inhibits 
cytokinesis without affecting nuclear division by preventing actin filament 
formation. This leads to cells forming a binucleated shape after undergoing cyto-B 
treatment. This is advantageous as the formation of a binucleated cell gives a 
confirmation that nuclear division has taken place, which cannot, as of yet, be 
identified when cyto-B is not used and mononucleated cells are analysed (Fenech, 
1997) (SeeFig. 2). The use of cyto-B results in the cytochalasin-b Micronucleus 
assay (CBMN). This is, given the confirmation of cellular division, the preferred 
method used in laboratories worldwide. For the MN percentages to be deemed 
accurate, 2000 cells as a minimum are required when analysing mononucleated cells 
after performing the MN assay or 1000 for binucleated cells when carrying out the 
CBMN assay (Fenech, 2000). By comparing the control percentage of MN to the 
dosed percentage of MN, it is therefore possible to calculate if chromosomal damage 








Figure. 2. (a) A MN originating from a lagging whole chromosome and acentric chromosomes 
fragments at the anaphase stage. (b) Shows the formation of a nucleoplasmic bridge from a dicentric 
chromosomes, the centromeres are pulled to opposite poles of the cell. Can also see the formation of 
an MN from the acentric fragment of the chromosome.  The role of cyto-B in stopping cells from 
dividing at the binucleated stage can also be seen. This is for a cell with two pairs of chromosomes 
(Fenech, 2000). 
1.2 Types of genotoxin 
 
i) Clastogens and Aneugens  
 
As previously mentioned, genotoxins causing chromosomal damage are split into 
two main group. Clastogens causing chromosomal breaks and damage and aneugens 
causing chromosomal loss to take place, with both leading to DNA damage as a 
direct result and the capability to be tested using the MN assay. More well-known 
clastogenic examples include Methyl methane sulfonate (MMS) (See Fig. 1) 
(Chatterjee and Walker, 2017). There are believed to be three major types of 
endogenous classes of clastogens (Emerit, 2007). The first class contain lipid 
peroxidation projects synthesised from arachidonic acid of membrane with aldehyde 
4- hydroxynonenal being a leading example (Emerit e al., 1991). The second class 
are cytokines, including tumour necrosis factor alpha (Emerit et al., 1995). The last 
category are uncommon nucleotides, with an example being inosine tri and 
diphosphate (Auclair et al., 1990). Aneugens are responsible for chromosomal loss, 
with the initial hypothesis stating that the MN produced by aneugens would be larger 
due to whole chromosome loss (Yamamoto and Kikuchi, 1980). However, it is a 
very difficult process to accurately check this due to the differences in chromosome 
sizes being an issue between species (Rosefort et al., 2004).  
Aneugens form MN through chromosomal loss (See Fig. 1). Colcemid is an example 
of a well-known aneugen with work being carried out for decades on its mode of 
action (Rudd and Hoar, 1991). Carbendazim is another example of an aneugen which 
has been studied extensively and used in our laboratory previously (Verma et al., 
2017 and Verma et al., 2018). Aneugens are thought to induce different shaped MN 
with these MN not perfectly circular in shape and thus a cause for concern as many 
machines, including automated microscopy have had difficulties in scoring these. 
Both classes of chemical cause serious cellular damage and the OECD have 
guidelines on the use of such chemicals and the classifications it belongs to (OECD, 
2011 and OECD, 2013). 
A general rule is applied in the pharmacology industry where under 1.5μg/tablet is 
considered a safe level of genotoxic substance for the majority of these chemicals. 
NDMA is among a select group of chemicals under an exception due to these being 









O6-methylguanine methyltransferase (MGMT) is a DNA repair protein responsible 
for the removal of alkyl adducts from the O6 position of guanine (Estellar et al., 
1999). The alkylation of DNA at the O6 position is formed as a response to either 
environmental pollutants, tobacco-based carcinogens and anticancer medication 
(Christmann et al., 2011). O6MG is however a secondary adduct, accounting for only 
around 7% of all adducts initially formed by alkylating agents, with N7-
methylguanine accounting for 65% of all adducts formed upon initial exposure 
(Liteplo et al., 2002). However, despite being a less common adduct, O6MG is 
highly mutagenic and has the greatest potential to lead to apoptosis (Kaina et al., 
2010). MGMT repairs O6MG by shifting the alkyl group to a cysteine residue in its 
active site (Christmann et al., 2011). Following this, the protein becomes inactivated, 
ubiquitinated and targeted for degradation by the proteasome (Xu-Welliver and Pegg, 
2002). Without MGMT present, O6MG forms point mutations, leads to double strand 
breaks which trigger apoptosis by due to cellular replication and DNA mismatch 
repair (MMR) (Ochs and Kaina, 2000). 
The most common environmental alkylating agents are the N-ntroso compounds with 
NDMA being the first N-nitro compound to be found as well as the most prevalent in 
the diet (Lijinsky, 1999). Thus, MGMT has the possibility to have great potential in 
the DNA damage/repair pathway in NDMA.  
The consequence of alkylation of O6 leads to cancer progression due to the similarity 
in conformation to adenine and thus pairing with thymine during replication (Estellar 
et al., 1999). This causes genomic instability (a hallmark of cancer (Hanahan and 
Weinberg, 2011)). Moreover, the change in base pairing caused from the alkylated 
O6 also leads to dysfunction and increases the chance of mutation, again leading to 
cancers. MGMT has been found to be manipulated by cancers in the response to 
anticancer drugs. A major mechanism of cancer resistance to drugs is by enhancing 
the activity of MGMT which thus counters the effect of DNA-alkylating 
chemotherapy drugs at the O6MG position (Fan et al., 2013). Therefore, MGMT can 
play both a positive role in repairing DNA damage at the O6 position and restoring 
the cell to a healthy status. But it can also play a negative role by reducing the 
effectiveness of anti-cancer DNA alkylating chemotherapeutic agents by countering 
the damage caused by repair (Christmann et al.,2011). 
b) O6BG 
 
O6-Benzylguanine was originally designed by focusing on the biomolecular 
displacement reaction between the leaving group at the O6 position of guanine and 
the MGMT protein (Dolan et al., 1985), (Dolan et al., 1990). Benzyl groups are used 
with more ease in biomolecular groups when compared to alkyl groups (Dolan and 
Pegg, 1997). When adding micromolar concentrations of O6BG, it was observed that 
MGMT levels were entirely depleted which led to increased sensitivity to O6guanine 
alkylating agents (Dolan et al., 1990). Because of these properties, O6BG is used 
greatly to sensitize tumours to lower doses of alkylating agents in a chemotherapy 
setting. However, due to its role in the depletion of the role of MGMT, it is possible 
to determine the levels of DNA repair ongoing whilst comparing samples when 
O6BG is added to samples when it is not. This leads to the determining the effect of 
DNA repair on nitrosamine compounds and specifically the nature of MGMT repair 
specificity in tandem with dose. By adding O6BG to control samples, it is possible to 
compare and gage levels of endogenous DNA damage taking place through the 
creation of O6MG and determine the effect of inhibiting MGMT DNA repair.  
c) Nuclear Stains 
 
In order to visualise cells appropriately, nuclear stains are used in the preparation of 
the cells for visualisation, be it manual microscopy, automated microscopy or flow 
and imaging flow cytometry. Different stains are used in tandem with different 
machinery accordingly to optimise the peak intensity levels of the specific stain. A 
nuclear stain is vital as it helps to differentiate an artefact of a similar size to true 
nuclear material, which is vital when carrying out genetic toxicology tests such as the 
MN assay. 
1.2.2C        i) Draq 5 
 
Deep Red Anthraquinone 5 (DRAQ5™) is a far-red DNA fluorescent dye used to 
stain nucleic acids and differentiate from debris in live or fixed cells (the latter being 
of more interest to this project).  (BD Pharmingen, 2017). DRAQ™ has a maximum 
excitation of 598/646nm but can also be used sub optimally with the 488nm laser 
(BD Pharmingen, 2017). By staining with Draq5™, it is possible to compare the 
brightfield and fluorescent images on the IDEAS® program during analysis and 
differentiate debris by its appearance in the brightfield image but lack of appearance 
in the fluorescent (DRAQ™ in this case) channel.  
 






1.2.2C      ii) Hoescht 
 
 
Hoescht 33342 Solution is a fluorescent reagent used in the staining of DNA and 
nuclei in live or fixed cells (just as DRAQ5™). Hoescht 33342 is advantageous due 
to its high specificity for double stranded DNA binding, with a preference for A-T 
binding (BD Biosciences, 2020). Thus, the dye is extremely useful in labelling 
double-stranded DNA and in turn the nucleus where the DNA resides. A blue 
fluorescence is emitted with a maximum emission at 461nm when binding to DNA 
(BD Biosciences, 2020). The specificity for DNA double-stranded binding allows for 
ribonuclease treatment to be skipped and non-specific RNA staining is avoided (BD 
Biosciences, 2020). 
d) Cell lines 
 
Human lymphoblastoid cells provide a comparable testing sample to use due to 
similarities in morphology to primary lymphocytes, therefore they have been used 
historically to model genotoxic systems (Verma et al., 2017). These cell lines can be 
differentiated into different subgroups, based on levels of cytochrome activity 
incorporated into the cell line.  
1.2.2d    i) TK6 cells: 
 
Human lymphoblast, thymidine kinase heterozygote form the more commonly 
known TK-6 cell line. These are frequently used in genetic toxicology in both 
industry and academia due to their suitability in the OECD test guidelines for the in 
vitro MN assay (OECD, 2014). TK6 cells are normally employed for chemicals 
without a need for metabolic activation due to the lack of cytochrome activity 
present. Cell lines derived from human lymphoblastoid cells are also larger in size 
than primary lymphocytes, this allows the cell lines to be used on a wider range of 
machines with reduced magnification capacity which is in turn cheaper for the 
laboratory and more accessible, allowing for a wider range of research to be carried 
out.  
 
1.2.2d    ii) Metabolically active cells 
 
 
1.2.2.d.2   a) AHH-1 
 
AHH-1 cell lines are, just as TK-6 cells, derived from human lymphoblastoid cells. 
Differentiating AHH-1 cells from TK-6 cells is the addition of the cytochrome 
CYP1A1 expression to a high level (Crofton-Sleigh et al, 1993). This allows this cell 
line to be used in the assessment of metabolically requiring test chemicals, whereas 
TK-6 cells cannot. The AHH-1 cell line is a ‘parent cell’ to the more metabolically 
competent MCL-5 cell line, which contains a plasmid containing an additional 4 
cytochromes. Thus, these two cell lines have great use in tandem with one another 
due to this similarity. The preparation methods are extremely similar, with the same 
media, horse serum and glutamine used for both. 
1.2.2.d.2        b) MCL-5  
 
Metabolically competent MCL-5 cells are also derived from human lymphoblastoid 
cells. These cells provide continuous expression of active cytochrome p450 
metabolic enzymes which explains why they are frequently employed in the 
assessment of test chemicals requiring metabolic activation (OECD, 2014). The cell 
line is a TK derived cell line with the AHH-1 cell line being the parent cell line, 
expressing only CYP1A1 (Crofton-Sleigh et al., 1993). The MCL-5 cell line also 
contains the cytochromes: CYP1A2, CYP2A6, CYP3A4, CYP2E1 in a plasmid, thus 
enabling greater metabolic output. This renders the MCL-5s more sensitive to potent 
metabolising carcinogenic compounds and provides a comparison with AHH-1 cell 
lines on which cytochromes are used in the metabolic processing of such test 
chemicals. Therefore, these two cell lines are ideal candidates to use in the 
assessment of test chemicals, such as NDMA. As mentioned previously, the 
preparation methods of MCL-5 cells is very similar to AHH-1 cells, with the 
exception that hygromycin is required to be added to the MCL-5 media in order to 
maintain the plasmid integrity, the plasmid contains a hygromycin resistance gene, 
therefore the addition of hygromycin allows for the selection of hydromycin resistant 




1.3 Micronucleus scoring methods 
 
i) Traditional scoring 
 
Currently, the MN assay is carried out by a variety of different methods and using 
different equipment, ranging from microscopy to the use of imaging flow cytometers 
and the scope for robotics. Traditional scoring methods for measuring MN have been 
based on light microscopy.  
In this manual approach, cells are stained with giemsa and manually counted to 
quantify MN. Giemsa staining is used as the dye attaches well to DNA rich regions 
and more specifically to the adenine-thymine rich regions. However, different stains 
can and are used, such as ‘Diff Quik’ (Lab- Aids, Australia) which is the 
recommended stain by Michael Fenech in his revolutionary paper on the MN assay 
(Fenech, 2000). The Diff Quik stain is a version of the Giemsa stain with a major 
advantage of streamlining the procedure from about 4 minutes to around 15 seconds.  
When undergoing fluorescent microscopy, acridine orange is the recommended stain 
to be used (Fenech, 2000).  
After the cells have been stained, the slides are examined by use of a light or 
fluorescent microscope. It is recommended that a magnification of 1000x is used 
when analysing peripheral human blood cells due to the smaller size of such cells 
compared to the commonly used immortalised cells (Fenech, 2000). To analyse the 
cells, both accurately and fairly, various measures are put into place to ensure this. 
The figure of cells required to be scored increases to 2000 when scoring 
mononucleated cells. Next, the MN analysed must be between 1/3rd and 1/16th the 
diameter of the main nucleus and have the same circular/oval shape. Moreover, a 
code is aligned to each slide so that the dosing applied to each slide is kept hidden to 
eliminate user bias. These steps maintain the integrity of the results produced and 
enable the MN assay to be used and approved by many regulatory bodies (OECD, 
2014 and ICHS2(R1), 2012). 
These are the reasons why manual scoring the cells via manual microscopy is still 
deemed to be the ‘gold standard’ (Vermat et al., 2017). 
There are therefore key advantages into the manual scoring of MN using light 
microscopy as with the gold standard. However, despite this method being the ‘gold 
standard’, there are evident issues present.  
The process is laborious, despite the use of dyes such as the Diff Quik to shorten the 
process, the procedure still takes much time and is tedious. The scoring can be 
subjective, despite the coding of the slides, a degree off opinions still exists and this 
can be vital when dealing with rare events. The subjective scoring can therefore lead 
to interscorer variability (Doherty et al., 2011). This, coupled with the lack of being 
able to truly archive results, somewhat limits the manual scoring approach and, 
though still considered the ‘gold standard’, makes true scoring difficult to achieve.  
 
  
ii) Semi-automated microscopy (Metafer). 
 
A new method developed to increase throughput compared to manual microscopy 
was automated microscopy. In this method, the slides prepared by microscopy can be 
automatically checked, resulting in a less laborious process of manual scoring, 
without sacrificing the integrity of true results. The Metafer™ system was a system 
produced and characterised in regard to MN work, it has been used, reviewed in 
papers such as Verma et al and compared to manual microscopy as well as flow 
cytometry approaches (Verma et al., 2017). This semi-automated system, where cells 
are stained with a fluorescent dye before being scored both in an automated and 
manual manner, allows for MN to be scored with greater ease and speed (Doherty et 
al., 2011). The stained slides are loaded onto the scanning platform, images of MN 
are taken using a 10x lens. These are then checked using a 100x lens in line with the 
coordinates shown in the display view (Verma et al., 2017).  This method, as well as 
being quicker, was shown to be reliable and produce results in line with traditional 
MN scoring (Chapman et al., 2014). There is also the tool of storing results for re-
evaluation and a dose-based system. This enables a level of inter scorer comparison 
to be made which cannot take place by manual scoring and increases confidence in 
the results seen. 
However, as seen in Table.1 there are flaws to the Metafer™ system. There is a lack 
of cytoplasmic staining, difficulty in differentiating MN overlapping the parent 
nuclei and the necessity to update the classifier setting conducting MN when scoring 
different cell lines (See Table.1). Moreover, there is a need to manually validate the 
images when scoring, which slows down the process and reduces the automation. 
Changing the classifier setting leads to the system producing an under estimation of 
MN frequency which is a limiting factor of its use (Verma et al., 2017). However, 
there is the potential to overcome this with the addition of a visual detection step 
(Decordier et al., 2009). Moreover, it can take further time to optimise setting for 
different cell lines and morphologies, which reduces the advantage of the systems 
speed. The cause of the underestimation is due to cells with novel nuclear 
morphology’s not being identified or large MN being misclassified as nuclei (Verma 
et al., 2017). Lastly, there is concern about the lack of visualising the cell membrane, 
this limits the use of this technology and is a major reservation of industry into the 
















Scoring Platforms Advantages Disadvantages 
Image analysis Manual microscopy 
(light microscopy) 
❖ Suitable for 
dose response 





❖ Suitable for MN 
scoring in the 
presence or the 
absence of 
cyto-B 
❖ Stained slides 
can be stored 
for a long time 
and can be re-
analysed 









❖ Slow, tedious 
and time-
consuming 
❖ Lack multiplexing 
abilities 
















❖ Suitable for 
dose response 




❖ Images of 
nuclei and MN 
can be stored 
for re-validation 
❖ Classifier settings 





induce MN via 
varied 
mechanisms 




small MN and 
manual 
validation of the 
images 





❖ Suitable for 
dose response 
❖ High content 
and high 
throughput 





❖ Cell lysis is 
required prior to 
MN scoring 











❖ Lack of MOA 
analysis with TK6 
cells 
Table. 1 An overview of the advantages and disadvantages of MN analysis using the 
manual scoring, Metafer™ semi-automated fluorescent microscopy and the 
MicroFlow® flow cytometry approaches to the MN assay (Verma et al., 2017). 
 
 
iii) Automated scoring (Microflow). 
 Due to the need to still manually ‘check’ the cells being scored using semi-
automated microscopy, and the laborious time associated with this resulting in this 
being a limiting factor, new systems were developed to increase the throughput of 
the assay. This led to the use of systemssuch as the MicroFlow® flow cytometric 
approach. This approach eliminates the laborious and time consuming approaches 
previously used and provides a high throughput, which is vital. Moreover, the use of 
nuclear stains like ethidium monoazide (EMA) allows for apoptotic bodies and 
necrotic cells to be differentiated from MN, this is often a challenge when manually 
scoring. Due to the lack of visibility of the cells, as there is no camera attached to the 
flow cytometry, as is the case with imaging flow cytometry which will be discussed 
shortly, it is ever important to use nuclear stains to ensure that MN scored are true 
MN as much as possible. The ability to score 10,000 cells in a minute is a true 
advantage and streamlines the scoring process, this is 15x quicker than manual 
scoring methods at least (Verma et al., 2018). This improves the laborious and 
tedious methods of manual and automated microscopy with visual scoring no longer 
an issue. 
However, the lack of visualisation is a major disadvantage of this system. ‘Double 
checking’ cannot take place and thus some confidence in results decrease. Also, not 
being able to store samples for a long period of time, in comparison to manual 
scoring and automated microscopy techniques where the slides can be stored for 
months, hinders this method considerably (Fenech, 2013). The lack of considerable 
storage of slides reduces the confidence in the results also by the lack of a ‘double 
check’ mechanism being in place by not having an archive of results. Another major 
disadvantage is the lack of differentiation between bi, tri and multinucleated cells 
with MN and cells with multiple nuclei (Verma et al., 2017). Furthermore, lysis of 
the cells occurs, leading to an overestimation of the MN count (Fenech et al., 2013). 
Due to the lysis breaking up more parts of the cell, more artifacts are produced, 
which are of a similar size and shape as MN and are thus sometimes miscounted as 
MN. Lysis of the cells is not recommended by Michael Fenech, as this can lead to an 
excess of debris which is difficult to differentiate from MN (Fenech, 2000).  
Moreover, there is also room for underestimations to take place on MN count, this 
combination of both MN overestimation and underestimation limits the use of the 
MicroFlow® and coupled with being unable to visualise the cells limit the use of 
flow cytometry in carrying out the MN assay significantly. 
 
iv) Imaging flow cytometry (Image stream and Flow Sight). 
 
Following the MicroFlow™, there was a need for an automated system for the 
assessment of MN to truly bring the approach into the 21st century. However, the 
major issue with the MicroFlow™ was the need to lyse the cell as well as the lack of 
visualising the cell. The result was the imaging flow cytometer: FlowSight® (Amnis, 
part of EMD Millipore). The imaging flow cytometer combines both the automated 
aspect of flow cytometry with the imaging of manual microscopy. The machine 
functions as a normal flow cytometer does, forward scatter with side scatter is 
available. With the base flow cytometric foundations, there is an additional bonus 
whereby each cell is captured as an image, this allows for each individual cell to be 
clicked on and analysed, adding an extra degree of confirmation. The tool is 
extremely powerful, magnifications range from 20x-60x depending on which model 
is used. The FlowSight® has a magnification of 20x, this is useful and allows for the 
comparison to microscopy to be made. However, this is not always a strong enough 
magnification when focusing on smaller events, such as primary lymphocytes. There 
is however, the Image Stream x Mark II® (Amnis, part of EMD Millipore) which is 
the more powerful version of the FlowSight®, this allows for magnifications of 40x 
to be achieved and ‘add ons’ can be applied to achieve a magnification of 60x which 
increases the capability of the machine and allows for crisper, cleaner images of 
events in focus. The greater magnification proves useful in the assessment of smaller 
cells such as primary lymphocytes, which cannot be visualised correctly on the 
FlowSight® due to being too small. 
Amnis boasts that the Image Stream x Mark II® has a high throughput with the 
ability to process thousands of cells per second. It is ‘intuitive’, ‘adaptive’ and 
‘boundless’ (Amnis imaging flow cytometer brochure, 2016). The camera in the 
Image Stream x Mark II® comes in varying pixel sizes, coming in at 0.1, 0.25 and 
1μm². The cells are lit up by means of a brightfield (BF) light-emitting diode (LED) 
side scatter laser and fluorescence is provided by one or more lasers. The emitted 
photons are collected by a ‘high numerical aperture objective lens’ (Rodrigues, 
2018). The photons pass through a spectral decomposition element which allows for 
a specific range of wavelength, 400-800nm in this case, to be separated (Rodrigues, 
2018). As they are separated, the charge-coupled camera (CCD) takes up to 10 
fluorescent images simultaneously at different parts of the camera for each cell. In 
combination with the two brightfield images produced, 12 images are taken per cell 
which therefore allows for high detail images of the cell to be obtained (Rodrigues, 
2018).   
Moreover, the machine arrives with 12 lasers, equipped for a variety of dyes and this 
fluorescent data is gathered alongside both brightfield and darkfield images, allowing 
for a high content, high integrity analysis to be carried out. The experiment is carried 
out without the need to lyse the cells, this being a key advantage over conventional 
flow cytometric approaches (Verma et al., 2018). The lack of cell lysis also is 
coherent with OECD guidelines where it is recommended that for MN scoring, the 
cells should have an intact cytoplasmic membrane (Fenech et al., 2013). The scoring 
metrics remain the same as per manual microscopy techniques. 1000 cells are scored 
for binucleated cells and 2000 cells for mononucleated cells.  
The initial applications to the MN assay were to manually analyse the images taken 
using the imaging flow cytometer manually. This can be carried out in a similar 
manner to manual microscopy scoring; however, the scoring does not need to take 
place on a microscope but on the IDEAS® program on a computer.  
The technique had been compared to manual microscopy in radiation dosimetry with 
the results found comparable (Rodrigues et al., 2014). This led to the approach being 
used when comparing chemical dosage with the results again found to be comparable 
(Haxhiraj et al., 2018 and Verma et al., 2018). This is vital due to manual 
microscopy still being considered the ‘gold standard’ (Verma et al., 2017).  
Experiments were carried out on primary lymphocytes extracted from the blood 
using the FlowSight® at a magnification of 20x. However, this proved not to be a 
strong enough magnification (Haxhiraj et al., 2018).  
The advantages of this technique are being able to access 20,000 cells within 
minutes, archiving the images produced and being able to further analyse these using 
the IDEAS® program to play a large factor in the current use of imaging flow 
cytometry in MN analysis. Moreover, the manual scoring on a laptop can be carried 
out in a less strenuous manner which can maintain that scorer subjectivity as scoring 
levels do not waiver and therefore consistent scoring is more likely to be achieved. 
Moreover, 12 channels provide a multitude of biomarkers and dyes to be used, which 
can help to further differentiate MN. The masks and templates present in IDEAS® 
also allow for a greater use of tools to query subjective MN. Lastly, the presence of a 
Brightfield image allows for the cytoplasmic membrane to remain intact and can 
allow for a composite image, containing the cytoplasmic integrity of a brightfield 
image, with the fluorescent identification ease of a DNA label to increase confidence 
in the users scoring. Specific images can be marked and rescored by other scorers 
and thus achieve a moderated standard.  
There are major disadvantages with the method currently, however. The images 
produced of the cells still must be manually scored, a laborious and tedious process. 
The imaging flow cytometers are also expensive, especially the ImageStreamX, 
which is required when analysing primary lymphocytes. This limits the quantity of 
laboratories with this equipment and with the service charge also being expensive, 
the method is limited to few laboratories. It is far more economically viable to buy  a 
microscope and the giemsa stain required to carry out the gold standard which allows 
for a more widespread use. Moreover, as manual scoring is still being carried out 
with the imaging flow cytometer, expertise is still required in the scoring stage. In 
order to make the expenditure of an imaging flow cytometer even more worthwhile, 
full automation is required for the MN assay. 
The manual scoring using the IDEAS® program allows for the next step in the 
process of complete automation to take place and is a key contributor to the next 
stage in the process: producing a deep learning algorithm to automate the MN assay 
fully. 
 
1.4 Analytical tools 
 
i) Use of IDEAS® program 
 
a) Background and explanation 
 
 
IDEAS® is the program which comes linked with the imaging flow cytometry 
platforms provided by Amnis. When the cells are processed by the imaging flow 
cytometer, the Inspire software (the computer program which comes as standard with 
the imaging flow cytometer) is automatically loaded up. A general gating system can 
be produced here and then the viable cellular data can be transferred to a memory 
stick and loaded onto the IDEAS® program. The program comes with unique 
features, enabling for the manual gating of the desired region and allows for each 
‘dot’ on the scatter plot to be clicked upon and visualised. Each image obtained also 
has an individual number attached to it, this image can be double clicked and copied 
to another region. This allows for cells containing MN to be visualised separately 
and the number attached allows for each image to be archived and checked again at a 
later date by a more experienced scorer if needed in order to ensure that the scoring 
integrity is kept. By being able to save different populations, it is possible to group 
and save rare phenotypes (MN, nuclear buds (N-buds) and nucleoplasmic bridges 
etc).  
b)  Template and Tools. 
 
The IDEAS® program has specific features and tools which allows for analysis to be 
undertaken more quickly. By applying specific features, the user can manipulate 
pixels which can allow for the differentiation of cells to be carried out with more 
ease. These features and mask can vary from simple metrics, such as ‘Spot intensity’ 
which allows for circular groups of pixels to be identified with more ease, to a 
combination of a variety of masks and features which in turn eliminate much of the 
cells and allow for much more specific phenotypes to be identified. This is the basis 
of some of the work which has been undertaken by Rodrigues (Rodrigues, 2018). By 
creating highly specific templates using complex masks and features in IDEAS®, it 
is possible to obtain specific phenotypes, be it MN, N-buds, Nucleoplasmic bridges 
or just binucleated cells. By combining features and masks together, it is possible to 
narrow down the quantity of cells deemed a specific phenotype. This allows for a 
pool of cells to be formed, with these cells being checked to confirm that the 
phenotype is what was thought. This speeds up the time taken to make up the 1000 
binucleated cells which are needed, but the manner is not perfected and this is why 
much work is being undertaken on producing an algorithm which is both quick and is 
comparable to the ‘gold standard’ of manual microscopy (Verma et al., 2017).  
c)  previous use and comparison (Rodrigues paper). 
 
The combination of masks and features in tandem was used by Rodrigues to create 
an algorithm which aligned with criteria set out by Fenech previously (Rodrigues, 
2018, Fenech et al., 2003, Fenech, 2007). This algorithm, set out for scoring the 
CBMN assay, reduces the scoring time required in manual scoring, this increase in 
scoring rate allows the assay to not only be performed quicker, but with more 
statistical integrity also (Rodrigues, 2018). In 2018,  Rodrigues, showed that the 
calibration curve produced using his algorithm had similarities to others produced in 
literature and therefore showed some promise (Rodrigues et al, 2016, Rodrigues, 
2018). The conclusion generated by this was that this method could produce 
radiation dose estimates to within +/- 0.5Gy of the actual dose, this is appropriate for 
triage radiation biodosimetry (Rodrigues et al., 2016).  Moreover, the four chemicals 
used in this study, two aneugens and two clastogens showed a significant increase in 
MN at all but the lowest two doses of Colchicine (0.005 and 0.01μg/ml and the 
lowest dose of VS (0.005μg/ml) (Rodrigues, 2018).  
However, it must be noted that the base MN level in the Rodrigues study was found 
to be 0.19% (Rodrigues, 2018). This figure is considerably lower than the historical 
MN levels in literature of between 0.32%-1.38% when using more traditional 
methods, such as microscopy and standardised flow cytometry (Lovell et al., 2018). 
The lower background MN rate is an area of concern and despite the advantages seen 
and produced by the algorithmic method applied here, ‘caution must be taken when 
attempting to draw conclusions based on comparisons between the experimental 
results presented here and published literature’ (Rodrigues, 2018).  
 
d) Next steps 
 
This latest attempt at increasing the throughput of the MN assay whilst retaining the 
integrity and accuracy of the results led us to the algorithmic approach we have 
undertaken. The next challenge was to keep the throughput high, but to produce a 
comparable result to the ‘gold standard’ of manual microscopy scoring (Verma et al., 
2017).  
1.5 Algorithm theory. 
 
i) Background and Origins 
 
In order to automate the assay, an algorithm would have to be created to allow for 
artificial intelligence (AI) to be used to significantly reduce the laborious nature of 
the test, whilst keeping throughput and accuracy at a level comparable to the ‘gold 
standard’. Two main methods branch out from this, machine learning and deep 
learning. 
ii)  Machine learning  
 
Machine learning, in regard to MN assay developmental, use revolves around writing 
a script which incorporates ‘structural rules’ into the script. These set of rules can 
then be used in the application of the MN assay. For the assay, a rule would be to 
search for a region with a diameter between 1/16th and 1/3rd of the main nucleus in 
the cell as per Fenech’s guidelines (Fenech, 2000). Moreover, an aspect ratio closer 
to 1 would signify a circular shaped MN. By combining these factors and more, as 
was carried out by Rodrigues, the resulting MN can be analysed, and a dose response 
carried out.  
Rodrigues carried this process out in the IDEAS® software, by manually inserting 
these guidelines of a MN by use of masks and features as specified earlier. Writing a 
machine learning algorithm is a way to streamline this process without the time-
consuming approach of having to create and modify many different masks and 
features. However, due to the ability to save templates on the IDEAS® program, the 
process is relatively streamlined for further use. 
The issue with the Rodrigues approach to automating the MN assay, and the Achilles 
heel of machine learning in this scenario, is that it is still very difficult to classify 
MN without manually analysing the MN individually. Due to certain MN not be 
perfectly circular, with a perfect circle being difficult to be capture when viewing a 
3D object in 2D, accuracy levels are not always as high as needed. 
The result is that images are captured of near perfect MN in phenotype,  The resulting 
cohort of MN produced are specific to the point of being over specific. This is 
advantageous in that no false positives are included; however, this is not a true 
reflection of the total MN in a sample and therefore cannot be reflective of the DNA 
damage taking place in the cell. This reduces the applicability of a dose response and 
does not forward the use of the MN test. This could be a reason as to why the 
background level shown by Rodrigues in his automation attempts were so low, as not 











Deep learning is seen by many as the evolution of machine learning, the next step in 
artificial intelligence. Despite seeming similar however, deep learning focuses on a 
different approach to solving problems and issues.  
With deep learning, fewer initial rules or structures are required. This makes the 
approach favourable when dealing with more complex issues, whereby one common 
theme does not necessarily apply to all the subjects. By attempting to mimic how 
neurones act in the brain, the deep learning algorithm comprises of a neural network. 
Where neurones in the brain link to one another and form connections, the neural 
network is split into different layers. Each layer communicates to another layer and 
passes its verdict to the next layer and so on. Thus, the more layers, the greater the 
computational demands of the network but also the added integrity of the results 
produced.  
In order to know what to look out for, the neural network is trained by a ‘ground 
truth’ of images. In much the same way that we learn to classify a ping pong ball and 
an American football as both being variations of a ball. We can distinguish the 
difference between these two variations, not only having experience with viewing 
both a ping-pong ball and American football, but by viewing the different types of 
balls in between, a tennis ball, golf ball etc. By having this bank of mental  images, 
we are able to identify the differences in identifying the different types of ball, much 
like the more ‘correct’ images the network can train with, the greater the accuracy. 
 Much in the same way, by producing images by which the network can learn from, 
the more images the better, the network can run these images through, layer by layer, 
to come to a verdict on the identity of each specific image. The network therefore 
improves, through the more images it scores and can also provide an accuracy level 
which is likened to how one would manually score the same image. 
b) Ground truth 
 
The ground truth is what provides the neural network with the initial data by which it 
can make decisions on unseen data. As such, it is important that the training data and 
validating data not be mixed, as this leads to an unrealistic and unreliable accuracy 
rating being shown and the network has not been tested with new data.  
In order to apply deep learning to the MN assay, images are needed of the varying 
cellular phenotypes. As such, mononucleates with and without MN, binucleates with 
and without MN, trinucleates with and without MN, quadranucleates with and 
without MN are all needed to be identified and incorporated into the teaching ground 
truth in order to differentiate between these different phenotypes and therefore 
identify MN and the resulting mononucleate or binucleate which is needed in tandem 
with the MN count in order to produce a %of Mn and thus a dose response.  
 
With a system needed to transcend the manual scoring of images which takes place 
during imaging flow cytometry scoring, an algorithm was still deemed the correct 
approach to the problem. The solution was different to the approach taken by 
Rodrigues. Whilst automating the manual scoring of images on the IDEAS® 
software seemed to be the answer in theory, the reality was that there were still many 
MN not scored in the data.  
The ‘ground truth’ of images which could be fed to the algorithm was the next step, 
with previous proof of concept experiments showing the use of imaging flow 
cytometry for manual scoring of cells, which could be applied in this case leading to 
a ‘ground truth’ (Verma et al., 2018).  
A ‘ground truth’ of images are a set of images of a specific phenotype. These images 
are checked in order to ensure the integrity of the image and this is a crucial step. By 
forming a ‘ground truth’ of images you know to be of a phenotype, the goal is to 
teach an algorithm this and let it adapt and develop the more data sets it can be 
process. Much like how we learn new information, by identifying the correct features 
when taught by a more experienced scorer and discarding other images, so the more 
you do it, the better you get. Thus, the more data the algorithm has at its disposal to 
analyse, the better it will be. 
 
iv)  Analysis and tools  
a) Transfer Learning 
i) ResNet Neural Network Use 
 
Therefore, by ensuing that the images scored in the ground truth were accurate, we 
hypothesised that a smaller set of ground truth images could be used successfully to 
repurpose the ResNet50 neural network successfully.  
By using an already established network, one could hypothesise that there was the 
potential to more accurately assess cellular images and place them into the correct 
corresponding category if the network had been trained on other images previously. 
As a result, this would lead to network familiarity with distinguishing images into 
differing categories (Warden, 2017).. As this principle is transfer learning, teaching 
the network 9 new classes would be achievable using a reduced bank of ground truth 
images was my hypothesis.  
 
 
ii) 3 channel approach 
 
The resulting approach was the use of 3 channels in the ResNet 50 model. 
Brightfield, Darkfield and Fluorescent channels were chosen. The Brightfield and 
Fluorescent channels are used in literature in IDEAS® imaging analysis to allow to 
distinguish artefacts from nuclear material for fluorescent stains and for the 
cytoplasmic integrity which can be shown in the brightfield channel, a significant 
limitation of the Metafer® semi-automated microscopy method (Verma et al., 2017, 
Verma et al, 2018). The Resnet model had limitations in repurposing the images used 
to initially define this network, which limited its use and led to the DeepFlow 







This 3-channel approach was taken forward, using ResNet50 as the network of 
choice and repurposing this network to score for cellular categories instead. 
However, the accuracy produced was not high enough to maintain the integrity the 
MN assay requires. Repurposing the network and adopting a transfer learning 
approach did not come to fruition, quite possibly due to the cellular categories being 
vastly different images to the images the network was originally trained on. This 
would lead to the network considering the cellular images to be more likened to one 
another and therefore not fully recognising each individual class. This possibly led to 
two sub groups of ground truth images being used by the network in assessing 
cellular images, one being the original images used to train the ResNEt50 network 
and the second being the cellular images used to create the cellular based ground 
truth in the IDEAS® program. This thus reduced the specificity of the network and 
therefore the integrity of the results. A scoring system which is not specific enough 
leads to false positives, which undermines the accuracy of the test.  
Therefore, after the master template created in IDEAS® proved to be too specific, 
the ResNet neural network proved to be not specific enough. Just as the nursery 
rhyme goes, one automation attempt had been too ‘hot’, one had been too ‘cold’, the 




To increase the network accuracy, the ResNet50 neural network repurposed approach 
was abandoned in favour of a newer, MN automation specific, neural network, 
DeepFlow. This network was created specifically to be trained on the ground truth 
generated. This was then tested with and without augmentation also. Augmenting the 
data can help to produce greater volumes of the rarer image categories by applying 
different measures (rotations, filters etc) to the images and thus creating multiple 
images from one. This can be extremely useful when only a small quantity of 
training images exists. However, did not prove useful in this scenario, and did not 
increase the accuracy. 
b) Adobe Bridge®  
 
Adobe Bridge® is a software tool commonly used by photographers to organise files 
and allows for renaming, assigning colour labels and star labels which allow for the 
files to be grouped together and analysed with like images. However, it was also 
found to be a very useful tool for grouping different cellular phenotypes in an 
efficient and accurate manner.  
The starring and colour coding system for grouping images allows for the different 
cellular morphologies to be separated with great ease. The starring system can be 
used to designate how many nuclei are present in the image. Be it 1 for a 
mononucleate, 2 for a binucleate, 3 for a trinucleate and 4 for a quadranucleates. 
When the cellular morphology is ambiguous or looks to be dead, the image can be 
labelled with a 5. Moreover, the colouring labels allows to further differentiate these 
images of cells in these categories into if a MN is present or not. If a MN is present, 
then the image can also be colour labelled with one of 5 colours. When analysing the 
images post scoring, the images can be differentiated by colour and/or by star rating, 
allowing for an easy export f the data. Moreover, there is the opportunity to zoom in 
and out of the images, which allows for further inspection of a cell when scoring is 
taking place.  
c)  MATLAB® 
 
To compensate for the differences in intensities and settings between imaging flow 
cytometers in different laboratories, whereby slight fluctuations in intensities and 
frequencies from various factors can make a difference,  MATLAB® was used to 
normalise the images produced by the imaging flow cytometers. The output of the 
normalisation is 8bit images which can then be analysed in order to form the ground 
truth. Moreover, for the images to be shown in Adobe Bridge®, the images have to 
be a one channel image. This is different to the images input into MATLAB® 
whereby the images are 2 channels with the images being in 2 different layers, 
brightfield and nuclear. Therefore, before the cells can be analysed to form a ground 
truth population on Adobe Bridge®, the file containing the images needs to be 





i)   General 
 
MATLAB® is a coding computing tool, whereby users can run their code and form 
algorithms for use in both machine learning and deep learning. The simplicity of 
MATLAB ® compared to other coding programs provides a great advantage. 
MATLAB ® does not require a computational language for the processing, such as 
python or java, and therefore makes the use of it easier for the user. By learning the 
rules and abbreviations required for the process of MATLAB ®, an understanding of 
the tasks can be undertaken.  
Moreover, MATLAB ® has many different toolboxes, including both machine and 
deep learning toolboxes, targeted to help individuals in the analysis and automation 
of data. 
The ‘Statistics and Machine Learning Toolbox’ helps users apply functions and apps 
in the analysis and automation of data (MATLAB ST, 2020). Moreover, statistics 
and plots are available for exploring the data and analysis. Visualisation and 
regression add-ons included allow the user to perform tasks more seamlessly with 
confidence in both 2D and 3D colourful graphs including scatter plots. This helps 
greatly in the ease of analysis whilst maintaining accuracy. 
The ‘Deep Learning Toolbox’ helps users to apply and analyse different levels of 
neural networks. It can allow more basic users to use shallow neural networks, with 
not much depth, but can provide proof of concept data for the application of neural 
networks into new areas of research (MATLAB DL, 2020). The application of deep 
learning neural networks is a more complex and computational heavy approach, 
which MATLAB helps to simplify when compared to other programs, without 
sacrificing the capability of the program to produce quick and accurate results. This 
toolbox provides pretrained models and applications as well as providing 
convolutional neural networks, the type of network used in this analysis to automate 
the MN assay. This toolbox includes applications including the vital ‘Train Deep 
Learning Network to Classify New Images’. This is a vital tool in the deep learning 
field, allowing for a convolutional neural network to be taught for the specific choice 
of the user, in this case the identification of MN and cellular morphologies required 
to achieve an accurate dose response. 
A convolutional Neural Newtwork (CNN) is made up of a series of layers, where 
each layer has a specific function. Once the image has gone through one layer, it 
connects to the next layer. The idea is to replicate how neurones work in the brain, 
however in the brain the neurones are attached to one another and to multiple other 
neurones. In this system, the layers proceed only to the next layer and the one 
previous. It is normally in the first layer, which is normally an image-Input-Layer 
which denotes the properties of the image which can be processed.  
The next layers in the network are normally pooling, rectified linear units and 
repeating blocks of convolutional layers. These are the core layers of building a 
convolutional neural network which can help to confirm filter weights, although 
these may be changed during the training of the network. This can be used during the 
training of this network to give the rarer MN phenotypes greater weight as there are 
less images to train with (MATLAB DL, 2020) 
The repeated blocks of convolutional layer acts to achieve a non-linear aspect to the 
network, allowing for an approximation to be made of non-linear functions which 
help to trace image pixels to the pattern of the image. Pooling layers allow for a 
downsample of the data as the network is flowing. However, caution must be taken 
with downsampling when using a more complex network with more layers as 
downsampling may take place too early and this can lead to the loss of important 
information from the image. 
 Moreover, this tool provides the user with the ability to adopt ‘transfer learning’. 
This can help by taking a pretrained network for use as an opening step for a new 
assignment, by updating a pre-existing network as opposed to creating a ne wone 
from scratch, the user saves time and convenience. The smaller quantity of training 
figure produced can then be transferred using their acquired features.  
A conventional way to avoid learning and validating the same piece of data is to split 
the original data, it is commonly carried out at around a 3:1 ration of training images 
to validating images. This ensures that enough images are used to accurately train a 
network but allows for enough images for the validation to be accurate also and 
provides a wide enough range of images (depending on the overall quantity of 
images used). 
Before the images can be trained, the code specifying the images has to include the 
properties of the images in order for these images to be correctly identified by the 
network. An image in the incorrect setting will not appear on the network.  
 
 
ii) Validation and error rate 
 
As the network is running to create a network, several features can be shown on the 
graph that is being produced. An accuracy and error rate are two of the main features 
that can be identified. By allowing the network more time to run at the beginning, the 
neural network has more opportunities to assess the images and form an assessment 
on what the likely category the image will belong in. At the beginning this error rate 
will be greater and the accuracy rate lower due to the network only having one 
opportunity to analyse the images and to learn from these. However, the accuracy 
rate should then increase and in tandem the error rate should decrease.  
A low accuracy rate can lead to two main conclusions. The first is that the training 
data is not of a high enough quality and the network is becoming confused as it is not 
being taught with a great enough detail. In this scenario, the network itself is not the 
issue but the training images. The issue can be seen more specifically if the issue is 
specified to only one or a couple of subgroups or if it the entire data set. This can be 
determined by analysing the confusion matrix (more detail will be provided of this 
shortly). It can be shown on the confusion matrix the accuracy of each individual 
subgroup and where the accuracy may be lacking. By analysing the images prdocued 
by certain sub-groups of the confusion matrix, the user is able to identify if the 
training data is up to a sufficient quality as these images will be manually assessed 
by eye and are open to counter-checking by other users, ensuring the integrity of the 
training data. 
The second issue may be that the training data itself is of a good standard but the 
issue stems from the network itself. This could be caused by too many pooling layers 
which may have taken vital information from the images and caused confusion. If 
there is an issue with the network, it would most likely be expected that each 
subgroup would show a lower accuracy rate and this thus resulting in a decreased 
overall accuracy rate.  
Lastly, the issue could an error with the network in combination with a lower quality 
or quantity of training images. In this case, each subsection would have to be 
identified and rectified MATLAB DL, 2020). 
 
iii) Epochs and Batch/Mini batch 
 
When training the network, it is important to consider the few factors based on the 
length of training. To maximise accuracy, it is not always beneficial to allow for the 
network to train for the greatest possible time-period to achieve the maximum 
accuracy. This may seem counter intuitive initially, however, after training for too 
long a period and more specifically too many epochs, the error rate can increase. 
This increase takes place as when training for an extended period of epochs, it is 
possible for the network to focus on specific features which are not true markers of 
the particular subgroup due to overtraining, akin for looking for patterns when they 
are not there in more popular culture. An epoch is defined as a complete training 
cycle on an entire data size.  
The batch size refers to the quantity of samples which will be put through the system 
at a time. The network runs through the number of images designated in the batch 
size and trains the network. It then goes through the second batch of images until it 
has gone through all the images in a sample, which is designated as an epoch. As an 
example, a batch size of 100 with an image bank of 1000 would go through 10 
iterations of images, each hundred, before training the network. Were the batch size 
50, this would increase to 20 iterations.  
There are both pros and cons to using greater or smaller batch sizes, with a balance 
needed. A smaller batch size requires less memory and thus less computational 
power is needed and a greater spectrum of computers can undertake the analysis. 
Moreover, when using mini-batch sizes, the network tends to train at a quicker rate 
due to the weights being updated after each iteration.  
The disadvantage is that the smaller the batch, the lower the accuracy shown of the 
gradient accuracy, with many more peaks and troughs shown due to each training 
step taking place after a smaller quantity of samples and therefore more fluctuation 
caused.  
 
Figure. 4 Schematic showing the difference between, stochastic, batch and mini-batch. 4 Far greater 
fluctuation seen in the mini-batch graph as opposed to the batch (Cross Validated, 2020).  
So, a balance must be struck when using batches and mini batches. Ideally, a greater 
batch size would be used, if computational power and time were not limiting factors 
in the analysis, as this leads to more images being sampled at a time and thus greater 
accuracy for each iteration. However, this is not always possible and thus the balance 
needs to be struck between computational power, time and accuracy. 
The validation is then plotted once per epoch and the change in accuracy as the 
epoch quantity increases. The quantity of epochs to let the network run for can be 
pre-set before once the optimal number is known. In order to recognise the optimal 
number of epochs needed to run the network, a free run must be carried out and the 
number of epochs denoted before the error rate begins to increase. 
 
 
v) Confusion matrix 
 
A confusion matrix is a table produced which summarises the performance of a 
classification algorithm. By producing a table detailing the accuracies of each sub 
class, the user can identify which classes are performing well and which class 
requires improvement.  
By producing an overall accuracy and error rate, it is possible to compare each class 
to the average accuracy and thus determine which class is performing better/worse 
than the average. It is important to take into account the quantity of images in each 
class, if one class makes up the majority of the images and accuracy, it could be 
possible that the overall accuracy is not as good as suggested as only one sub class 
may be performing and thus inflating accuracy levels. 
By showing the user the accuracy and error rates of each sub class, as well as a total 
accuracy and error rate, it is possible to distinguish where each sub class may be 
scoring incorrectly and this can help the user to identify issues and to implement 
ideas to improve the total accuracy.  
Thus, by displaying the data in a table displaying the accuracy rates of each class, the 
user can easily identify areas of strength and weakness and look to rectify these for 
greater future accuracy (MATLAB DL, 2020). 
 
 
1.6 Aims and Objectives 
i) Different Laboratories 
 
The combination of the different laboratories helped to contribute to the ground truth 
and carrying out the dose response analysis. The Cardiff and Cambridge formed the 
ground bank of cellular images which formed the ground truth. Moreover, a Cardiff 
dataset was also used in forming a dose response. A separate dataset was used from 
the Imaging flow cytometer at the Newcastle Laboratory, and this was used in a 
dataset and compared with the Cardiff dataset to carry out a dose response analysis 
of the non cyto-B MN assay. Lastly, the GSK dataset was used in calculating a cyto-
B MN dose response comparison between manual scoring and the deep learning 
automated method developed and analysed in this project. Moreover, this GSK 
manually scored dataset has the potential to be used in future to create a larger bank 
of ground truth images. The use of these different laboratories allows for 
reproducibility to be demonstrated across data formed across different laboratories.  
ii) Aims 
 
Therefore, the aim of the project was to develop a method to automate the laborious 
and time-consuming nature of the traditional MN assay (manual scoring), without 
compromising the accuracy shown traditionally in what is the gold standard.  
By using and applying a deep learning neural network approach to this issue, images 
can be manually scored by a user and divided into groups to form a ‘ground truth’ of 
images. This ground truth, is then used to teach the neural network the parameters of 
the cellular images to assess in order to carry out the scoring of the assay. Having 
this form of ground truth removes any user subjectivity to the results. Moreover, 
using different laboratories in the creation of this ground truth, allows for the method 
to be an inter-laboratory application, capable of making the assay high throughput 
and accurate. 
Developing a system whereby a high throughput is developed, whilst maintaining the 
gold standard accuracy, would streamline the assay and allow for greater use yet of 
this and transform its use into a truly 21st century approach. 
2.0 Materials and Methods 
 
i) Chemicals 
Carbendazim (Cas no. 10605-21-7), purchased from Sigma-Aldrich. The working 
concentrations, 0.00, 0.40, 0.60, 0.80, 1.00, 1.20 and 1.60 (µg/ml) were selected 
based on the data produced by Verma et al., 2017. Not all concentrations were in 
specific laboratories, where only three doses were used in addition to a control. 
 
ii) DNA staining  
DRAQ5™ DNA (Cat. No. 564902 supplied from BD Biosciences) was used to label 
nuclei and MN for the Cardiff and GSK laboratories . Samples incubation time for 
DRAQ5 was a minimum of 20 minutes.  
Hoeschst 33342 (Cas No. 87576-97-1, supplied from Sigma-Aldrich) was used to 
label nuclei and MN for the Cambridge laboratory.  
These datasets were used in the creation of the ground truth. 
These staining events were previously carried out and the images of the cells 
used and re-purposed in order to create the ground truth of the different 
cellular morphologies.  
 
iii) Cell lines and treatment  
 
Human lymphoblastoid TK-6, AHH-1 and MCL-5 cells were obtained from 
American Type Culture Collection (ATCC), Manassas, VA, USA. AHH-1 and 
MCL-5 cells have a doubling time of 22-24 hours. The cells were cultured in RPMI 
1640 media (Gibco, Paisley, UK), supplemented with 1% Glutamine (for MCL-5 
cells specifically 40 μg/mL Hydromycin) and 10% heat inactivated horse serum 
(Gibco, Paisley, UK). Cells were seeded at 1x105 cells/ml in 25cm2 flask (Fisher 
brand), incubated at 37°C in a humidified atmosphere of 5% (v/v) C02 and 
established into subcultures once confluence was reached. When carrying out the 
experiment, cells were seeded at 2x105 cells/ml in 25cm2  for 1.5-2 cell- cycles in the 
presence of genotoxic agent with no recovery. 
Tk6 cells have a doubling time of 13-15 hours (Lorge et al., 2016). The cells were 
cultured in RPMI 1640 media (Gibco, Paisley, UK), supplemented with 1% 
Pen/Strep (100 U/mL Penicillin and 100 μg/mL Streptomycin) and 10% heat 
inactivated horse serum (Gibco, Paisley, UK). Cells were seeded at 2x105 cells in 
25cm2 flask (Fisher brand), incubated at 37°C for 1.5-2 cell- cycles. 
 
The in vitro MN assay was used to assess MN formation in the TK6, AHH-1 And 
MCL-5 cells with following treatment with Carbendazim, or in the case of the MCL-
5 and AHH-1 cells; a water and methanol control. Cells were treated, and then 
incubated for 1.5-2 cell cycles. After incubation, the cells were centrifuged at 200xg 
for 10 minutes in preparation for harvesting. The supernatant was then removed, and 
the pellet re-suspended in 10mL of phosphate-buffered saline (PBS) (Gibco®).  
iv) Data acquisition on the imaging flow cytometers and IDEAS analysis® 
 
After the removal of the test chemical, cells were washed with PBS and fixed with BD 
FACS™ lysis solution (CAS- 349202) ratio FACS lys:dH2O 1:10 to allow for 
membrane permeabilization and cell fixation. Two ml of the fixative was added to 
each pellet and incubated at room temperature for precisely 12 minutes. The cells were 
then spun at 200xg for 10 minutes and the staining process was carried out. During 
this staining process, the nuclei and MN are stained with 0.05mM DRAQ5™ (CAS-
564902, BD Biosciences) and incubated at room temperature prior to acquiring the 
images with the FlowSight® and ImageStreamX-MkII®. 
The 488nm laser, found as part of FlowSight®, and the 405nm, used in the 
ImageStreamX-MkII®, are both equipped with at least three lasers and were used to 
excite DRAQ5/Hoescht 33342 stained cells. Hoescht 33342 was used for the 
Cambridge laboratory, Draq5 was used for the: Cardiff, Newcastle and GSK 
laboratories. This led to images being captured automatically with the use of 
INSPIRE® 3.0 software. In order to acquire these images, 80µl of the stained cell 
suspension was inserted into the FlowSight® or ImageStreamX-MkII® and the 
resulting DRAQ5/Hoeschst 33342 cellular images were processed, along with 
brightfield images to enable later analysis. 
Aspect ratio and area features were used from the brightfield images to gate out any 
debris or cells which had died from the population as they would be irrelevant in this 
analysis. Altogether, 20,000 single cells were captured per dose per replicate.  
MN frequency was obtained by scoring 2000 Mononucleated cells per dose for the 
non-cytochalasin-B MN assay and 1000 Binucleated cells for the cytochalasin-B MN 
assay where possible using FlowSight imaging flow cytometer. The data was then 
saved as a raw image file and analysed in IDEAS® version 6.2 using either manual 
scoring of images or the creation of templates. For analysis to take place on 
IDEAS®, the raw image files (rif) are converted to compensated image files (cif) and 
then to data analysis files (daf).  
 
Once on IDEAS®, manual scoring of previously scored data was checked and 
‘pulled out’ to form a population of a specific phenotype. The ‘master template’ was 
formed using masks and features on IDEAS® and was updated as required for each 
different data set. This template was used to help to ‘pull out’ different populations 
with more ease and increase the ‘ground truth’ pool.  
 
By brainstorming the specific morphologies of different cell types, it was possible to 
use masks and features on the IDEAS® software to differentiate between these cell 
types and therefore form multiple templates within the master template for ‘pulling 
































Figure. 5 An overview of some of the masks and template used in the IDEAS® software for the 
master template creation in an attempt to automate the MN assay through this method. 
A) Shows a portion of the variety of masks used within the analysis of the master template. 
B) Shows a portion of the variety of features used within the analysis of the master template. 
C) An example of how specific populations of cells can be differentiated from one another using the 
characteristics of a particular phenotype, in this case how binucleated with MN cells would be 




v) IDEAS® based Ground truth 
 
This ground truth was generated in two different ways. One way was to score images 
of the cells manually as has previously been undertaken (Verma et al., 2018). The 
other method was to manually score a selection of cells via IDEAS® and to confirm 
the cellular phenotypes. This was undertaken until a master template was formed on 
the IDEAS® software. A master template was formed by a variety of masks and 
features which are found in IDEAS®. These masks and templates helped to 
differentiate cellular phenotypes and allow for different populations to be ‘pulled 
out’. Like much in the same way that Rodrigues attempted to automate the MN 
assay, we used an approach which is likened to an extent (Rodrigues, 2018). 
However, each data set of the ‘pulled out’ populations was analysed manually to 
ensure that they belong in the phenotype assigned. These formed part of the ‘ground 
truth’. The advantage of forming a ground truth via this method as opposed to 
carrying out the entire experiment as such is that an underestimation of MN which 
may occur is not problematic as there are more data sets from which to analyse more 
MN. 
This master template was tweaked to work from different data sets due to different 
laboratories providing data and using different lasers, thus subtle changes will be 
needed to the masks and features to normalise the different datasets. This is as 
different laboratories have different channels opened and corresponding to the 
frequencies; thus the ‘nuclear channel’ may not be in the same channel across the 
different laboratories and the subsequent mask would have to be edited to ensure that 
a nuclear mask would be encompassing the nuclear channel for the specific dataset. 
This includes adapting the channels set out in the masks based on the laboratory due 
to different channels used (The fluorescence channel may be channel 5 in some 
laboratories and then channel 11 in others etc).  Different nuclear dyes used appear in 
different channels during imaging flow cytometry analysis and thus the same master 
template cannot be used for these differing data sets. 
 The aim was that the deep-learning algorithm will replicate the results produced in 
historical data. If this occurs, then this project could help to lead a significant 
advance in increasing the throughput of the MN assay and revolutionise the assay 
truly. 
vi) IDEAS® analysis 
In an effort to reduce the laborious and time-consuming approach of manually 
scoring MN on the IDEAS® software, a master template was created to produce a 
level of automation in MN analysis. This approach was coined using the masks and 
features tools available in IDEAS®. By producing a template which could identify 
the features of a MN, the other cells would be gated out and a MN % obtained, 
allowing for MN analysis and thus insights into chromosomal damage. This 
approach was based on the Rodrigues approach (Rodrigues, 2019).  
vii) Training the network 
To train the network, two sets of ground truth images were first analysed using the 
Adobe® Bridge platform. For the images to be in the correct format in 
Adobe®Bridge, they must be in an 8-bit tiff format. To generate this tif, the 
IDEAS® program is opened and a raw image file (.rif) generated by the inspire 
software is opened. This automatically produces a compressed image file (.cif) and a 
data analysis file (.daf). The .CIF file directory was copied and applied to a MatLab® 
code. This MatLab® file is used to convert a cif file to the individual tif file 
containing the cellular images: 
Final_script_3_channel_from_cif_to_tif.m 
This script is opened on MatLab® and the cif directory is pasted onto the relevant 
line for validations. The result of this is the creation of tifs. These tifs then need to be 
converted to a 1 channel tiff in order to be visualised using the Adobe®Bridge 




 script allows for tif 1 channel conversion. The images are saved in an updated one 
channel folder and ready to be analysed.  
 
viii) Bridge analysis 
 
The images in a single channel tiff format, obtained from the cif file conversion were 
opened on Adobe®Bridge which is a file manager where images can be marked with 
5 different colours and 5 different stars. The images were scored according to the 
following criteria:  
A single * denotes a mononucleated cell. 
Two stars ** denote a binucleated cell.  
Three stars *** denotes a trinucleated cell. 
Four stars **** denotes a quadranucleated cell. 
5 stars, denotes a cell which is either dead (apoptotic or necrotic) or unscorable, this 
category is known as ‘others’.  
Colours are also used to annotate these images. By pressing a number 6, a yellow 
colour is denoted. This is used to signify a MN, so that cells with MN are split by 
how many main nuclei are present in the cell also. A mononucleated cell with a MN 
would be signified by a single star * and the colour yellow. When analysing the cells, 
the user can distinguish between all cell classes and those in the class with and 
without a MN, as well as being able to view the total MN number, regardless of the 
number of main nuclei in the cell. 
 
 
2.1 Running the network 
 
i) Creation of .cif files in IDEAS 
 
In order to run the network, the raw image file (.rif), generated using the INSPIRE 
software from the imaging flow cytometer, is opened in IDEAS®. When the user 
opens the .rif file in IDEAS®, a compressed image file (.cif) and a data analysis file 
(.daf) are automatically generated. The .daf file is the file which allows the user to 
view the data on IDEAS®. It is using this .daf file, where the user makes a note of 
which channels are used for: brightfield, darkfield and DNA fluorescence. It is 
important to make a note of this as the channel order differs based on the imaging 
flow cytometer machine and the DNA stain used. It is this .cif file which is needed 
when running the script to determine a dose response. 
 
ii) Generating tif files for Deep Learning 
 
1. Open MATLAB and open the script ‘final_script_3_channel_from_cif_to_tif.m’ 
2. Make all the bioformat files are in that directory together with the image padding 
script 
3. In the script make sure to change the channel numbers to get the right images in  
4. Change the cif file name/location in the script and choose a directory to store the 
images 
 





iii) Test images on a previously trained network 
  
1. Open MATLAB and open the script ‘explore_output_v2.m’  
2. Alter the network model parameter file in the script, it is a .mat file which 
currently looks like this ‘DeepFlow25-Feb-2020-17-47-23-Epoch-100.mat’ 




When carrying out a dose response, it was integral to carry out analysis to check if 
the data was normally distributed or not in accordance with the methods highlighted 
in Johnson et al., 2014. The initial test used to assess the normality of the data is a 
Shapiro-Wilk test, where a P value of >0.05 equated to the data being normalised. If 
this was <0.05, then a Bartlett’s test can be carried out to assess normality in the data, 
with a P value of >0.05 showing the data being normalised. The log of the data and 
square root can also be obtained for use in assessing normality of the data if required.  
To carry out a one-sided Anova, a Dunnett’s test in this case, the data must be 
normally distributed. This is as the one-sided Anova calculates variation between 
dosed samples and the control and thus relies on data to be normally distributed in 
order to calculate this. If the P value is <0.05, then the dose is of significance 
compared to the control, if the P value is >0.05, then the dose is not significant 




































The original methodology for the creation of the ground truth was to use the 
IDEAS® program, which allows for the differentiation of cellular categories by the 
use of masks and features as displayed in Figure. 5, Figure. 6 and Figure. 7.  
Limitations with proceeding in this method led to the ground truth creation taking 
place by using the Adobe®Bridge approach for manually placing different images of 
cells into different categories, Table. 2 formed the basis of the categories to use and 
images to be analysed manually. The result of this manual scoring of the different 
categories of cells and their quantities is displayed in Figure. 9, Figure. 10 and 
Figure. 11. A further dataset which could be used in future work shown in Figure. 12.  
The Cambridge ground truth was the first ground truth to be generated using this 
approach. Fig. 9 shows the distribution of the Cambridge network with 9178 cells 
scored in total. This is a far smaller figure than is used in literature for neural 
network training, where millions of images are routinely used to accurately train 
networks. The golden rule has historically been, to use 1000 images per categories, 
and in many cases, 1000 categories are used, yielding the million images used which 
was eluded to earlier (Warden, 2017). 
 
As shown in Table. 3, where over 99% of cellular images are being assessed into the 
others category, the 3-channel: brightfield, fluorescent, darkfield approach could not 
be used going forward as the network was being confused and not allowing for 
useful information to be obtained as a result. This led to the 3-channel approach to be 
used, consisting of, a singular brightfield channel with two fluorescent channels. This 
was then further reformed to a two-channel approach, consisting of a single 
brightfield and fluorescent channel in use, with the increase in accuracy displayed 
form Table. 4 to Table. 5. This 2-channel approach was carried forward, following 
determination of the most accurate networks derived from Table. 5. 
Network 3 therefore proved to be the more accurate network across all these 
categories, which on first glance makes it seem like the Cardiff dataset is the more 
accurate of the two (since both were validated on the Cambridge ground truth). 
However, on reflection, the two networks were trained using differing levels of 
epochs, with Network 3 using the optimal 20 epochs and Network 8 using the sub-
optimal 30 epochs (Table.4). Given the presence of over-training, it would be 
expected that a larger disparity would have been shown between the two networks 
than a 0.4% difference in overall accuracy (Table.4). The MN accuracy differences 
are both under 10%, with an 8.4% difference in binucleated MN cell accuracy and a 
1.9% difference in mononucleated MN accuracy (Table.4).  
 
 Network A displaying the highest accuracy for Mononucleated MN and thus what 
would be used for carrying out the non cyto-B MN assay. Network D displayed the 
highest accuracy levels for Binucleated cells with MN and thus this network would 
be used for the determination of a cyto-b MN assay.  
A dose response was therefore carried out, using both the cyto-b MN assay and the 
assessment of Binucleated cells and the non cyto-b MN assay and the assessment of 
Mononucleated cells and this is shown in Figure. 14, Figure. 15 and Figure. 16. A 
manual assessment was carried out using the cyto-b MN assay and this was 
compared to chosen networks deemed to have the highest accuracy as a comparison, 
including Network D and compared in Figure. 14. The manual scoring of 
mononucleated cells was not carried out, instead a dose response was generated 
using the more accurate neural networks as was carried out for the Binucleated cells 
(See Figure. 15). Moreover, a comparison of the Cardiff and Newcastle Carbendazim 
data-sets was carried out and compared to the historical background rate of MN in 
non cyto-B MN assays in literature (See Figure. 16). Figure. 17 Shows a proof-of-








Fig. 6 An example of the components of a mask used in the IDEAS® attempted automation 
of the ground truth. The channels set for the mask must be manually adjusted for each 









Fig. 7 Progression of part of the master template, detailing the Binucleate MN 
template. The specificity becomes greater with each graph, as each graph gates off 





Fig. 8 Example of the flow found differentiating cellular groups in IDEAS®. This 
allows the user to identify which population they wish to view. A feature useful 
when calculating the MN% using IDEAS® and helpful in initial ground truth 
formation 
i) Ground truth grouping 
Cellular Phenotype Set 1 Set 2 Set 3 Set 4 
 Set 
5 Set 6 
 Set 
7 Set 8  
Sum 
Total 
Apoptotsis 289 477 
 
495 
    
1261 
Binucleates 909 1381 
 
53 
    
2343 
Binucleates with MN 5 11 8 1 7 10 4 9 55 
Binucleate-Overlapping 651 558 
 
846 
    
2055 
Mitotic 139 41 
 
22 
    
202 
Mononucleates 1222 1689 
 
2025 
    
4936 
Mononucleates with MN 5 19 5 6 8 4 3 6 56 
Necrotic 8 20 
 
13 
    
41 
Nuclear buds 3 1 1 2 4 1 0 0 12 
Nucleoplasmic Bridge 
Binucleate 11 0 6 3 11 5 4 0 40 
Nucleoplasmic Bridge 
Trinucleate 2 1 2 2 4 5 1 2 19 
Nucleoplasmic Bridge 
Quadranucleate 0 0 0 0 0 0 0 0 0 
Quadranucleate 30 25 15 18 17 9 16 24 154 
Quadranucleate with MN 2 0 0 0 0 1 0 0 3 
Quadranucleate Overlapping 22 12 7 18 11 3 12 17 102 
Trinucleate 147 142 
 
207 
    
496 
Trinucleate wih MN 6 5 2 3 3 1 6 3 29 
Trinucleate Overlapping 56 71 32 69 12 19 59 69 387 




Table. 2 The phenotypic breakdown of the initial ground truth created using the IDEAS® 
program in the original automation attempt, using the Cambridge data set with Hoescht 
33342 as the DNA stain. This formed the basis of the ground truth image bank before 



















154 28 387 496
Apoptotic Binucleated MN cells
Binucleated cells Overlapping Binucleated cells
Mitotic cells Mononucleated cells
Mononucleated MN cells Necrotic Cells
Nuclear bud cells Binucleated Nucleoplasmic Bridged cells
Trinucleated Nucleoplasmic Bridged cells Overlapping Quadranucleate cells
Quadranucleated MN cells Quadranucleated cells











Mononucleated cells Mononucleated MN cells Binucleated cells
Binucleated MN cells Trinucleated cells Trinucleated MN cells












Figure. 9 Distribution of manually scored cellular images from the Cambridge data set. 
Cellular images manually analysed using AdobeBridge® software based on cellular 
phenotype. Data represented as %’s in the Pie Chart, however, depicting quantities of cellular 
images. 9178 cells scored in total in B+C. These cellular splits were used in the creation of 
the neural networks, which were used to asses dose responses in the MN assay. 
A) The original distribution of the Cambridge data set, after initial IDEAS® grouping, featuring 
a wider range of phenotypes to which the cells were attributed to. 
B) Distribution of the cells following initial analysis on AdobeBridge® and regrouping. ‘Others’ 
category added and increased accuracy. 
C)  Distribution of the cells following re-analysis of all MN validated from the network using 
MatLab® and the confusion matrices to pinpoint potential mis-classifications. Most accurate 










Mononucleated cells Mononucleated MN cells Binucleated cells
Binucleated MN cells Trinucleated cells Trinucleated MN cells




















Mononucleated cells Mononucleated MN cells Binucleated cells
Binucleated MN cells Trinucleated cells Trinucleated MN cells










Figure. 10 Distribution of manually scored cellular images from the Cardiff data set. Cellular images 
manually analysed using AdobeBridge® software based on cellular phenotype. Data represented as 










Mononucleated cells Mononucleated MN cells Binucleated cells
Binucleated MN cells Trinucleated cells Trinucleated MN cells










Mononucleated cells Mononucleated MN cells Binucleated cells
Binucleated MN cells Trinucleated cells Trinucleated MN cells
Quadranucleated cells Quadranucleated with MN Other Cells
C 
cellular splits were used in the creation of the neural networks, which were used to asses dose 
responses in the MN assay. 
A) The original distribution of the Cardiff data set 
B) Distribution of the cells following analysis on AdobeBridge® and regrouping.  
C) Distribution of the cells following analysis of all MN produced from the network using 
MatLab®. Most accurate ground truth 
 
 
Figure. 11 Combination of the distribution of manually scored cellular images from the Cambridge 
and Cardiff data sets combined. These data-sets combined are used as another dataset in the training 
and validation of the networks. Cellular images manually analysed using AdobeBridge® software 
based on cellular phenotype. Data represented as %’s in in Pie Chart, however, depicting quantities of 
cellular images. 19,521 cells analysed in total. These cellular splits were used in the creation of the 










Mononucleated cells Mononucleated MN cells Binucleated cells
Binucleated MN cells Trinucleated cells Trinucleated MN cells
Quadranucleated cells Quadranucleated with MN Other Cells
 
 
Figure. 12 Distribution of manually scored cellular images from GSK data set. Cellular 
images manually analysed using AdobeBridge® software based on cellular phenotype. Data 
represented as %’s in the Pie Chart, however, depicting quantities of cellular images. 25,805 cells 
analysed in total. This data set was not used in the creation of a neural network and could be 
helpful in future work as provides scope for a 3rd laboratory data-set to be used in tandem 










Table. 3 Table showing a great proportion of cells were analysed as others when using the 3-










Mononucleated cells Mononucleated MN cells Binucleated cells
Binucleated MN cells Trinucleated cells Trinucleated MN cells
Quadranucleated cells Quadranucleated with MN Other Cells
Dose (µg/ml) Scored as Others Others (%) 
0 29,900 99.67 
0.8 29,817 99.39 
1.2 29,801 99.34 
1.6 29,814 99.08 












































Cambridge Cardiff 77.5 15.3 95.4 63.2 
Network 
1 

























Cardiff Cambridge 75.3 34.7 86.6 38.6 
 
                     
Figure Legend: Dark grey fill = Networ ks post Cardiff ground truth update 
Light grey fill = Following initial 2 channel network accuracy 
No Fill = original ground truth datasets used 
Table.4 Table showing neural network accuracies at different stages of the ground truth 
update. Binucleated Cell MN Accuracy’ and ‘Mononucleated Cell MN Accuracy’ columns are in 
bold due to being the most important factors when deciding the ‘best’ network to use for a dose 
response. ‘Binucleated Cell MN Accuracy’ determines the network for use in a cyto-B dose dependent 
MN assay. ‘Mononucleated Cell MN Accuracy’ determines the network for use in the non cyto-B 
dose dependent MN assay. The table is sorted by Mononucleated MN cell accuracy, from most 




Figure Legend: Gold = Best accuracy, Silver = 2nd best accuracy, Bronze = 3rd best accuracy. 
 
Table. 5 Table showing accuracy levels of the neural networks following training and validation on 
the latest updated Cardiff and Cambridge ground truths. ‘Binucleated Cell MN Accuracy’ and 
‘Mononucleated Cell MN Accuracy’ columns are in bold due to being the most important factors 
when deciding the ‘best’ network to use for a dose response. ‘Binucleated Cell MN Accuracy’ 
determines the network for use in a cyto-B dose dependent MN assay. ‘Mononucleated Cell MN 
Accuracy’ determines the network for use in the non cyto-B dose dependent MN assay. The table is 















































































































Figure. 13 Confusion matrices produced post neural network creation using MatLab®. Training on the 
‘Cardiff’ dataset and validation also on the ‘Cardiff’ data set. Overall accuracies shown as well as 
accuracies per individual subgroups.  
A) Neural network formed after using the first updated ground truth and using a 3-channel approach 
of Brightfield, Fluorescence, Fluorescence, Network 1 produced this confusion matrix.  
B) Neural network formed after using the first updated ground truth and the 2-channel approach of: 
Brightfield and Fluorescence. Network 2 produced this confusion matrix.  
C) i) Neural network formed post Cardiff and Cambridge ground truth updates and the 2-channel 
approach of: Brightfield and fluorescence (1, 11). Network C produced this network                                                                                                 
ii) Figure showing the training development of Network C up to 20 epochs. Accuracy and error rate 
are both shown. 
iii) The results section after completing a network run, showing the accuracy rate of the network 
produced after completing 20 epoch cycles, other key statistics are also shown, such as iterations 
taken and time elapsed.  
 
 
iv) Dose Responses 
 
 
Figure. 14 Comparison of cyto-B MN dose response assay treating with Carbendazim and 
assessing using 4 triplicates from the neural network complex and one manually scored 
triplicate collected by the ImageStreamX-MkII®. Network 8, 3, 5 and D were used. N=3, 














Figure. 15. Development of non cyto-b MN dose response assay treating with Carbendazim. The 
Newcastle data set was assessed for neural network accuracy development. Networks 2, 3 and A 
were used in analysis for comparison of the different ground truth stages. N=3, Mean = +/-- 



















Figure. 16 Comparison of Cardiff and Newcastle non cyto-B Carbendazim dose responses 
using the automated neural network A. N=3ˠ, Mean = =+/- StError Increase seen from 
control in both laboratories at the top dose and similarity shown between datasets. *Denotes 
a significant dose dependent increase (P<0.05) 











Fig. 17 Comparison of background MN rates in two different cell lines, MCL-5 and AHH-1 cells, 
using a TK6 derived ground truth neural network, to compare the ability of the ground truth to assess 




























































Figure. 18. Comparison of background MN levels in MCL-5 cells with and without O6BG in a 
solvent control sample. Assessment using the neural Network automation method to determine 
capability of using a TK-6 cell trained neural network on other cell types with and without O6-



































MCL-5, No O6BG MCL-5, +O6BG
 
 





























Figure Legend: Blue arrow denotes continuation onto the next step in development. Green arrow denotes a new step in 
the process added in. Red arrow denotes a step abandoned in order to improve accuracy levels. 
Figure. 19. Flow-chart showcasing the development of the systems used to automate the MN assay, from the IDEAS 









i) IDEAS® Template formation 
 
The IDEAS® program is the recommended program working in tandem with the 
imaging flow cytometry equipment and the INSPIRE software which, linked to the 
imaging flow cytometer, allows for the conversion of the raw data (RIF) into an 
electronic format and provides initial gating analysis.  
Due to the ease of access of the software, an initial attempt was carried out to fully 
automate the MN assay using a combination of masks and features within the 
IDEAS® program to allow the user to apply the template and determine the quantity 
of MN found. This hypothesis was further cemented by literature in the field, 
including Rodrigues’ attempts to automate the MN assay using the ImageStreamX-
MkII®flow cytometer (Rodrigues, 2018). However, Rodrigues made adjustments to 
the guideline outlined by Fenech in his guidelines for a MN with the MN size set to 
between 0.89-13.3μm² as opposed to the 0.40-11.1μm² range which would adhere to 
the guidelines of MN having areas between 1/256th- 1/9th of the main nuclei (Fenech, 
2000 and Rodrigues, 2018). This is acknowledged by Rodrigues, who cites artifact 
prevention as the reason for the alteration. By adding extensive templates and masks 
to determine healthy from alive cells (as shown in Fig. 3), it was our aim to eliminate 
extensive changes to the MN guidelines. Moreover, when comparing to Rodrigues’ 
method, a background MN rate of 0.19% was observed by Rodrigues, which he once 
again acknowledges to be slightly lower than the historical range of 0.32%-1.38% 
(Lovell et al., 2018 and Rodrigues, 2018). In previous research in our laboratory, a 
background MN range of around 1% was consistently found (Verma et al., 2018). 
Moreover, in my own analysis (in Fig. 20, a background MN% of no less than 0.53% 
was determined. This is a threefold increase on the finding from Rodrigues and 
therefore reduces confidence in the significance of the dose response due to this far 
lower background MN figure).  
By brainstorming the features which specify cellular phenotypes, it was possible to 
form the masks and features necessary to separate these into different classes (as 
shown in Fig. 3). (Fig. 4 shows the pathway which is used to determine a cells 
phenotype) and by using the graphs in IDEAS® to determine the cut off points, it is 
possible to view a select population and the cells considered to be in that specific 
population. In IDEAS® the user is able to then view each individual cells plot on a 
graph and therefore, the minima and maxima regions of a specific are can be 
extended or shortened if it can be visually analysed that a number of ‘correct’ cells 
are falling outside of the region (an advantage of imaging flow cytometry over 
conventional cytometry). This was used constantly to ensure that the correct features 
and thresholds were incorporated into the analysis. The brightfield and fluorescence 
channels were used in tandem as has been traditional in imaging flow cytometry MN 
analysis (Verma et al, 2018). The fluorescent channel allows artefacts to be 
distinguished so a false positive is obtained and the brightfield channel allows for the 
integrity of the cytoplasm to be checked so as to confirm if the cell is in a healthy 
state Verma et al, 2018). 
The resulting ‘master template’ produced did accurately gate MN as was the aim; 
however, the gating was found to be too specific. Only ‘perfect’ MN were picked up 
by the strict guidelines the masks and features created in the template. The result was 
that a low level of non-MN were found to be produced as a result of the mask, as was 
the initial aim. However, by enforcing strict guidelines into the gating of the MN, not 
enough MN were gated due to not all MN having a ‘normal’ MN morphology. Some 
MN do not adhere to these specific guidelines and therefore are not gated and not 
deemed MN. This was reported by Verma et al, whereby aneugens and clastogens 
can have a different effect on the resulting MN formed (Verma et al., 2018). 
Moreover, there was a need to update the masks based on which channels the 
different labs were using (this differs based on which nuclear stain was used due to 
different frequencies exciting different stains). This proved to be time-consuming 
and reduced the effectiveness of automating the system. However, it would be 
possible to create variations of the master template for differing nuclear stains for 
long term efficiency.  
This led to an under-estimation of the MN count which in turn affects the use of such 
a system in a dose response system. One would expect a dose response to be shown, 
but the levels would not adhere to historical data and therefore the comparison 
potential is limited. This limits the use in applying the technique to unknown doses 
and severely impacts the use of this approach going forward. Therefore, these 
limitations added more difficulty to the automation attempt on the IDEAS program 
and can be attributed to part of the reason the automation attempt on IDEAS® did 
not work in the manner required to automate this assay truly whilst maintaining 




ii) Ground truth creation 
 
Due to these limitations, the new approach was taken outside of IDEAS® and the 
idea of deep learning came to the fore, whereby the data collected in the IDEAS® 
approach could be adapted to form a ‘ground truth’ which would teach the network 
what a MN should look like by, as opposed to the ‘machine learning based’ approach 
carried out in the IDEAS® program which carried too much specificity.  
By forming the ground truth by manual scoring on IDEAS®, it was possible to 
generate a ground truth to teach the neural network which was as accurate as 
possible. The accuracy was vital, as any incorrect images distorted the accuracy of 
the neural network. Adobe®Bridge, a tool commonly used in photography analysis, 
proved to be a useful tool in the creation of the ground truth for the neural network. It 
allowed for ease in scoring and allowed to differentiate MN scored cells from non-
MN containing cells of the same nucleic quantity. However, despite the network 
scoring images in an initial 3 channel manner, the images were manually assessed 
using a singular channel, whereby the fluorescent image was found to be the most 
accurate channel for the individual scoring of cellular images. By only being able to 
look at the fluorescent images in the ground truth creation process, it was possible for 
cellular categories to be more difficult to be differentiate, especially with the large 
quantity of cellular types originally used in Table.1 and Fig. 5.  
It is clear, by looking at Fig. 5 that 1000 images are not reached for categories other 
than: Apoptotic (1231), Binucleated (2343), Overlapping binucleated (2055) and 
Mononucleated (4419). This shows that out of the 17 total categories used in Fig. 5a, 
only 4 contained images over the historical threshold, less than 25% of the total 
categories. This can be attributed to the great difficulty in generating 1000 images of 
the rarer phenotypes such as MN or Nucleoplasmic bridges to an even greater extent. 
The background levels of MN in literature are 0.32-1.38% (Lovell et al., 2018). This 
would require 100,000 control dosed cells to be manually scored to give around 1000 
MN which is a laborious and time-consuming approach to solve an already laborious 
and time-consuming method. The highest dosed cells could also be analysed; 
however, this would require carrying out RPD studies and carrying out dilutions in 
order to dose the cells and increases the labour-intensive nature of the automation 
process. This would increase the experiment time and would be further increased due 
to the vast amounts of categories used and number of categories containing sub 
optimal levels of images. 
 
iii) Alteration of categories, ‘Others’ added 
 
It was decided to introduce a category called ‘others’ which would replace the dead 
and unscorable events. By adding this category, it was possible to condense the 
images into more specific categories, by removing areas of ambiguity, thereby 
allowing for less confusion to take place between categories due to a variety of 
reasons. In the first instance, as there are less categories, there are less opportunities 
for the cellular images to be placed into the incorrect category, as we reduced the 
categories from 17 to 9 as seen in Fig. 5. Moreover, the categories which were 
merged in Fig. 5b and onwards, were similar morphologically in Fig. 5a. This can be 
shown by the bi/tri/quadranucleated overlapping cells were grouped together with 
their nucleic counterparts of the same quantity. This allowed for less confusion by 
placing these in the same category. It must be noted, that due to the images being 
manually assessed in the fluorescent channel, the cytoplasm could not be visualised 
in the same way and therefore more difficulty was seen in differentiating apoptotic 
cells from necrotic in Fig. 5a. Adding the ‘others’ category also ensured that 4/9 
categories now contained more than 1000 cells in Fig. 5b. This is an improvement 
from 23.53% to 44.44% in categories containing more than 1000 cells, almost 
doubling. Lastly, categories such as nuclear buds and MN are very similar 
morphologically, that having these in two different categories provides the neural 
network with an impossible task in differentiating the two, which would then result 
in the confusion of the network when attempting to distinguish between the two 
categories. The new grouping of categories therefore allowed  the network to better 
predict the category a cell should fall in to and this categorical approach was chosen 
going forward due to the increased confidence in the number of images in each 
category and the stark differences between the different categories, which was not 
the case previously. 
 
iv) Optimal epoch count  
 
 
The epoch count is one of the most important variables to consider when dealing 
with neural network analysis. By increasing or decreasing the epoch number, the 
network can be allowed longer to train and learn from the images. However, a 
balance must be met, as the error rate can also increase if left to run for an extended 
period, which can harm accuracy levels.  
This was shown in Fig. 12a) which was run for 30 epochs and produced only a 
74.1% overall accuracy. More importantly than the overall accuracy, are the 
accuracy levels for the mono and binucleated cells with MN categories. A 44.4% 
accuracy is shown for binucleated cells with MN and a 51.4% accuracy for 
mononucleated cells with MN. When this is compared to Fig. 5b), a lower overall 
accuracy is seen, 74.1%<83.5%, lower binucleated cell accuracy, 70.4%<94.1% and 
lower binucleated MN cell accuracy, 44.2%<59.5%. The binucleated and binucleated 
MN percentage accuracy is important in assessing neural network accuracy due to 
the analysis of this phenotype when undertaking the cytochalasin-B MN assay. 
Given the rarity of MN cells when carrying out a dose response, it is vital that the 
binucleated MN cell accuracy is as high as possible, a more important factor than 
overall accuracy and binucleated cell accuracy.  Given the importance of this 
category, a 15.3% increase in accuracy in the 20-epoch sample is a significant value 
but could be improved further. When assessing mononucleated cell accuracy, there is 
an increase from 77.8% to 92.3% and an increase from 51.4% to 72.4%. An increase 
of 21% is shown when comparing the 30-epoch network 8 to the 20-epoch network 
9, whereby the two networks have both been trained and validated on the same 
Cambridge dataset, using identical ground truth populations. Identical channels have 
been used in both cases: brightfield, fluorescence, fluorescence. Therefore, the 
increase in accuracy between network 8 and network 9 can be solely attributed to the 
reduction in epoch frequency from 30 to 20. Given this increase in accuracy shown 
from Fig. 5a to Fig. 5b, 20 epochs were chosen going forward to be the optimal 
epoch frequency. Fig. 5dii) shows the accuracy and loss rates per epoch/iteration 
level. A reduction is not shown in the accuracy level up to the 20-epoch level or an 
increase in loss ratio. When the accuracy level starts to decrease and the loss rate 
increase, it is indicative of over training the network, whereby the network over 
focuses on a specific, non-important, area than what it was intended for. Therefore, 








v) Cardiff ground truth generation 
 
The Cardiff ground truth was generated in much the same way as the Cambridge 
ground truth. However, since the others category was already found to be 
advantageous previously, the cellular category was adopted immediately when 
creating the ground truth for this dataset. When viewing the cellular splits of the 
Cardiff ground truth in Fig. 19a, 3/9 categories, 33.33%, contained more than 1000 
cellular images. All 3 of these categories totalled over 2000 cellular images in fact. 
Interestingly, less trinucleated cells were generated in the Cardiff ground truth when 
compared to the Cambridge ground truth, 1287 compared to 463 when comparing 
Fig. 5b to Fig. 19a. The Cardiff ground truth was once again drawn from the 
Adobe®Bridge software package, with the star rating system once again being used 
successfully. An important note is that the Cardiff laboratory uses Draq5 in the 
nuclear staining of cells, whereas Cambridge use Hoescht 33342. Indeed, it is 
impressive that these two nuclear stains can both be used in tandem on two different 
datasets and generate high levels of accuracy.  
As there were now two ground truth data sets in the shape of Cardiff and Cambridge, 
it was now possible to analyse combinations via training on one set and validating on 
the next, this will be explained in greater detail. But one hypothesised that the 
difference in nuclear stains used may be a leading factor in some of the variation 





vi) Darkfield channel abandoned 
 
Following the creation of ground truth from two different laboratories, the network 
was created in order to determine the most accurate combination between training 
and validations sets. However, before this could be undertaken, the 3-channel 
approach of: brightfield, darkfield and fluorescence was revised. 
Each individual image the neural network uses, is split into 3 images, containing a: 
brightfield, fluorescent and darkfield image. It is by using the training data, 
consisting off all 3 images in 1 (although only the fluorescent channel was assessed 
in manually scoring the ground truth into categories, the extra layers were used to 
add information and therefore increase accuracy). The others rate was greatly 
reduced when the darkfield channel was abandoned in favour of another fluorescent 
layer. This can be shown when comparing the others percentage in the final GSK 
dose responses (35.49% of cells as others), a great reduction from the over 99% 
shown in Table. 2.  
`The decision to add an extra fluorescence layer instead of an extra brightfield layer 
was made after assessing the accuracy levels produced by the network using the: 
brightfield, brightfield, fluorescence combination.  
The added fluorescence accuracy is not surprising for a few different reasons. The 
images which were assessed for the ground truth creation were fluorescent images 
and thus adding more weight to these would be thought likely to result in an 
increased level of accuracy. Moreover, adding an extra fluorescent channel makes 
the 3 layered image, 2/3rd /66.67% fluorescent (Verma et al., 2018, Haxhiraj et al., 
2018). This is similar to the weighting of the fluorescent channel in IDEAS® when 
creating a composite image, created using the brightfield channel and fluorescent 
channel, whereby the fluorescent channel is set to around 70% intensity in order to 
be able to distinguish nuclear material from artefact but still maintain the 
cytoplasmic integrity that the brightfield channel offers (Verma et al., 2018). 
Therefore, similarities can be made in the creation of a doubly weighted fluorescent 
channel using the 3-layered neural network image approach. By abandoning the 
darkfield approach and forming tiff images in the new brightfield, fluorescent, 
fluorescent manner, the neural network was used to train and validate on the ground 






vii) Network Training and Validation Analysis 
 
The original Cardiff and Cambridge ground truth datasets were used to originally 
create neural networks. The two most accurate networks produced using the initial 
ground truth classifications were: 
-Network 3 (See Fig. 20), training using the Cardiff data set and validating using the 
Cambridge dataset. 
-Network 8 (See Fig. 22), training and validating using the Cambridge dataset. 
Network 3 produced the highest overall accuracy: 74.5% compared to 74.1%, the 
higher binucleated cell accuracy: 82.9% compared to 70.4%, the higher binucleated 
MN cell accuracy: 52.6% compared to 44.2%, the higher mononucleated cell 
accuracy: 96.6% compared to 77.8% and the higher mononucleated MN cell 
accuracy: 53.3% compared to 51.4% (Table.4, Fig. 20, Fig. 22).  
Given the unusually small difference, especially in the mononucleated MN cell 
accuracy, it was determined that the Cardiff ground truth may have some outliers 
present in the ground truth creation, which were distorting the network accuracy. 
This was decided as the probable cause of the lower than expected accuracy shown, 
over issues such as epoch number and differences in nuclear intensities. For epoch 
length, there was a clear reduction in epoch count at 30 epochs was shown in 
comparison to 20 epochs, as can be shown by the in Table.4, when viewing the 
comparisons between Network 8 and 9. For differences in nuclear intensities, by 
comparing Network 3 and Network 9 (both validated on the Cambridge but trained 
on different data sets), a higher differential was shown in the more generic 
categories, such as binucleated cell accuracy (12.5% (Table. 4)) and mononucleated 
cell accuracy (18.8% (Fig. 20, Fig. 22)) when compared to the MN containing 
images (8.4% and 1.9% (Table.4) most likely caused due to the misplacing of MN 
cellular images having a greater effect on the MN category due to the rarity of this 
phenotype and thus each individual image carrying greater weight in relation to the 
category.  Thus, to ensure the ground truth integrity was as high as possible, analysis 







a) Cardiff Validated MN analysis 
 
To further improve the accuracy of the neural networks, the ground truth population 
from the Cardiff dataset was analysed and any outlier images were identified and 
moved into the correct category. This was carried out in MatLab® by using the 




 This is the script used in producing a neural network, such as those shown in Table.4 
and Table.5. The script contained the specific line of code:  
 
Idx=find(imdsValidation.Labels==’Mononucleates with MN’ & 
YPred==’Mononucleates with MN’) 
 
This line of code showed images which had been, in this particular case, placed into 
the ‘Mononucleates with MN’ class for training, but had also been validated by the 
network as ‘Mononucleates with MN’.  
This line of code can therefore be used to check the cellular images have been placed 
into the correct categories. The images were produced in windows containing 36 
images each, with a number assigned to each individual cellular image from 1-x (the 
last cellular image applying to that category). The numbers relating to the individual 
cellular images were then shown in the command window of MatLab®, where the 
numbers 1-x corresponded to the full-length tiff number for that specific image. 
When analysing this data, cellular images which were not deemed to be of the 
cellular phenotype to which they were originally assigned, were updated and placed 
into the correct category. By then applying the results obtained, the cellular images in 
the incorrect file could be dragged and dropped’ into the correct folder. The example 
shown here was ‘Mononucleates with MN’, but all the cellular categories were 
applied, and the images manually assessed for any discrepancies.  
By applying this method of quality control on the ever important ground truth class, 
the ground truth was refined and the updated ground truth used to train and validate 
the Cardiff and Cambridge ground truths once again, resulting in more accurate 








b) Re-analysis of Network combinations 
 
By having a Cardiff and Cambridge data set ground truth available, it was possible to 
assess network accuracy in 4 iterations: 1) Training with Cardiff, validating with 
Cardiff, Network 1 (Fig. 13), 2) training with Cardiff, validating with Cambridge, 
Network 4 (Fig. 20), training with Cambridge, validating with Cardiff, Network 6 
(Fig. 21) and training with Cambridge, validating with Cambridge, Network 9 (Fig. 
22). 
Each network combination was assessed, and accuracies compared to find the 
network most suitable for use in the automated MN dose response. Network 1 (Fig. 
13) showed the greatest overall accuracy at 93.8%, in contrary to Network 4 (Fig. 20) 
which only showed a 73.7% accuracy, a great 20.1% difference. Network 1 (Fig. 13) 
also showed the highest binucleated cell accuracy, with a respectable 98.4%, on the 
contrary to Network 4 (Fig. 20) which showed only 75.3%, a large 23.1% difference. 
It was also shown that Network 1 (Fig. 13) had the highest binucleated MN cell 
accuracy at 71.8%, which was 56.5% greater than Network 6 (Fig. 21) which only 
had a 15.6% accuracy level. Thus, if one were to carry out the cytochalasin-B MN 
assay, Network 1 is clearly the network of choice. However, despite Network 1 being 
the most accurate and showing great specificity in identifying binucleated cells, 
however, with only an accuracy of 71.8% (Table. 4) for binucleated MN cells, the 
levels were not quite high enough to maintain the integrity of the MN assay and as 
such improvements to the network were made, which will be expanded on shortly. 
When assessing the mononucleated cell accuracy for potential non-cytochalasin-B 
use, Network 1 (Fig. 13) was again found to have the highest accuracy level for 
mononucleated cells at 96.9%. However, unlike with the binucleated cells, even the 
worst network for predicting mononucleated cells Network 4 (Fig. 20), still 
maintained an accuracy of 86.6%, a difference of just 10.3%, far smaller than the 
23.1% difference observed in binucleated cell accuracies (Fig. 9, Fig. 20). When 
comparing mononucleated MN accuracies, Network 9 (Fig. 22) shows the highest 
accuracy with 72.4%, whilst Network 4 (Fig. 20) shows the worst at 38.6%, a 
difference of 33.8%. Moreover, just as with the binucleated and binucleated MN 
cells, a large difference is seen between the differences in accuracies with and 
without MN present. The ‘Mononucleated MN’ highest accuracy level of 72.4% 
(Fig. 22) is still not optimal accuracy levels for use in the MN assay.  
It is also somewhat unsurprising that the best accuracy levels for MN at this initial 
stage, were both obtained via training and validating on the same datasets, due to the 
same nuclear stains being used in both. It was interesting to note how the Cambridge 
network gave the highest accuracy levels for mononucleated MN cells (Fig. 22), 
whereas the Cardiff dataset provided a greater accuracy level to binucleated MN 
cells (Fig. 13). After this analysis, I was interested on ways to improve the network 
accuracy, focusing predominately on improving MN accuracy levels, due to the 
cellular accuracies levels being far greater and at above 90% for mononucleated and 
binucleated cells (Fig. 13).  
The difference to the original dataset can be viewed by the differences in accuracies 
shown when compared to the updated ground truth dataset. The highest overall 
accuracy in the updated network is 93.8%, an increase of 19.3% when comparing the 
updated Network 1 to the older Network 3 (Table.4). Indeed, a 15.5% increase is 
viewed in the binucleated cell category, a 19.2% increase in binucleated MN cell 
accuracy. Moreover, this trend is reduced in the mononucleated cell accuracy using 
the same networks, where only a 0.3% increase is shown and only a 0.5% accuracy 
in mononucleated MN cell accuracy. Therefore, an improvement was made by 
updating the ground truth, especially in the binucleated cell category. This 
improvement suggests that the original ground truth did contain some outlier images 
in the incorrect category which reduced the accuracy levels.  
However, a cause for concern in the analysis of the neural network accuracies was 
the sub-par performance shown when cross-network validation was carried out. The 
different intensities of the lasers and slightly different conditions across different 
laboratories can provide an explanation for lower accuracies, despite such attempts to 
reduce this factor by normalisation. Network 4 which is trained on Cardiff and 
validated on Cambridge and Network 6 which is vice versa, showed worryingly low 
levels of accuracy in the binucleated cell MN category (Table.4). Accuracy levels of 
34.7% were shown by Network 4, with Network 6 showing 15.3% (Table.4). This 
accuracy level is a further reduction of 17.9% lower than the best network using the 
original ground truth populations (Table.4). This is problematic for the technique, 
since cross validation is a sign of reproducibility between laboratories and would 
need to be improved going forward if this technique is to be adapted on a larger 
scale.  
Cross laboratory validation allows for a single network to be applied to a host of 
laboratories, forgoing the need to create a ground truth for each new laboratory. As 
well as showing that cross laboratory reproducibility could be obtained using 
differing nuclear stains also. Since the Cardiff ground truth was updated, the fault 
must fall with the Cambridge ground truth or a fault associated with the images 














viii) 2 channel approach  
 
Following the inconsistencies shown in the 3-channel approach, where the cross-
validation training networks were not shown to be as accurate as required, a 2-
channel approach was taken going forward. This two-channel approach consisted of 
a fluorescent and brightfield channel each being used in equal proportions, with the 
extra fluorescent channel being sacrificed.  
In order for this approach to be carried out, the ‘two_channel_tiff_reader’ was 
employed in order to create a new batch of tiff images in 2 layers, as opposed to the 3 
layers used previously. This was carried out in much the same manner as the initial 3 
channel tiffs, a somewhat laborious process. Care was taken to ensure that the correct 
channels are used, due to different channels corresponding to the brightfield and 
fluorescent channels used in the Cardiff and Cambridge networks.  
Once the tiffs had been created for the 2-channel approach, training and validation 
was undertaken using all permutations of training and validation, including cross-
laboratory valuation and the results evaluated. 
 
a) Re-analysis of all network combinations using 2 channels 
 
The ‘DeepFlow’ neural network was again used and the accuracies evaluated. 
Network 5 had the highest overall accuracy at 93.7%, highest Binucleated cell 
accuracy at 99% and highest Mononucleated cell accuracy at 95.9%(Fig. 20) (Table. 
4). Network 2 showed the highest accuracy level for binucleated MN cells at 86.5% 
and Mononucleated MN cell accuracy at 71.4% (Fig. 13).  
It is important to note, that Network 5 had the greatest accuracy shown in 3/5 of the 
main categories, despite being a cross-validation network, which shows the great 
increase the 2-channel approach had on accuracy levels. The success of the cross-
validation approach widens the scope for potential wider scale use of this approach. 
When compared to the previous 3-channel approach, using the same training and 
validations datasets (training on Cardiff and validating on Cambridge), a 20% 
increase was shown in overall accuracy, a 23.7% increase in binucleated cell 
accuracy, a 66.6% increase in Binucleated MN cell accuracy, a 9.3% increase in 
Mononucleated cell accuracy and a 29.3% increase in mononucleated MN cell 
accuracy (Fig. 10) (Table.4). Therefore, a substantial increase was shown in both 
mononucleated and binucleated cell accuracy, with a focus on the binucleated cell 
increase.  
Altogether, the 2-channel approach increased the accuracy of the rarer phenotypes, 
with a 14.7% increase shown on the previous best binucleated MN cell accuracy 
(Network 2 compared to Network 1, see Table.4). Some of the other major categories 
did take a slight decline (when comparing the most accurate network used in each 
system), overall accuracy decreasing by 0.1%, mononucleated cell accuracy 
decreasing by 1% (Network 5 compared to Network 1, see Table.4). However, these 
minute detractions are more than accounted for by the great increase in the 
binucleated MN cell category.  
However, the mononucleated MN cell accuracy was not shown to improve in the 2-
channel approach, a decrease of 1% shown when compared to the previous network 
creations (Network 2 compared to Network 9, see Table.4). Interestingly, the 
Network 2 accuracy of 72.4% was the highest mononucleated MN cell accuracy 
shown on datasets validated on the Cardiff network, a testament to the increasing 
accuracy of the 2-channel approach and the updated ground truth. However, 
throughout the previous networks, it had been the dataset validated on the Cambridge 
network which has shown the highest mononucleated accuracies. This brought up the 
idea of updating the Cambridge ground truth also in much the same way the Cardiff 
ground truth had been updated. This was supported again due to the ranking of 
accuracies in this 2-channel approach, whereby the networks were ranked by 
totalling the accuracies of mono/binucleated cells with and without MN and showed:  
 
Network 2>Network 5>Network 7>Network 10.  
 
It is unsurprising that Network 2 is trained and validated on the Cardiff dataset, 
Network 5 is trained using the Cardiff dataset and Network 7 is validated using the 
Cardiff dataset (Table.4). This leaves Network 10 at the bottom, the only network not 
containing any Cardiff influence (Table.4). Therefore, I concluded that there was a 




b) Cambridge validated MN evaluated 
 
 
The Cambridge ground truth was evaluated in the same way as the Cardiff data set, 
with the MN assessed using the following script in MatLab®: 
 
 Idx=find(imdsValidation.Labels==’Mononucleates with MN’ 
&YPred==’Mononucleates with MN’). 
 
By assessing the MN produced, it was possible to re-assign cells into the correct 
category if they were previously placed incorrectly. By re-assessing the Cambridge 
ground truth, both ground truths had been evaluated and updated, ensuring greater 
accuracy levels. This process was even more important due to the smaller total 
number of MN cells in the ground truth due to the rarity of the MN phenotype, 0.32-
1.38% (Lovell et al., 2018).  
When assessing the MN found in the original ‘others included’ ground truth, 150 
Mononucleated MN cells were included and 154 Binucleated MN cells (See Fig. 
9b)). Post-updated ground truth, these numbers were reduced to 127 Mononucleated 
MN cells and 121 Binucleated MN cells (See Fig. 9c)). The Others category was 
increased on the other hand, from 1257 originally to 1372, suggesting that some MN 
cells may have been too ambiguous in morphology and thus confused the network 
and thus produced a lower accuracy (See Fig. 9b) and Fig. 9c)). The ratio of 
mononucleated MN cells to Mononucleated cells pre-update showed a ratio of 
1:12.88. This was increased to 1:16.20, owing to the more specific regulations placed 
on MN scoring, resulting in a greater frequency of others and mononucleated cells. 
The binucleated MN cell to binucleated cell ratio pre-update was 1:25.14, which was 
increased once again to 1:30.47.  
Thus, a reduction in MN cells was shown in the final Cambridge ground truth, 
increasing the specificity of MN scored cellular category and ensuring that all the 





c) Re-analysis of network combinations following Cambridge evaluation.  
 
Following the analysis of the Cambridge ground truth and the introduction of the 
updated ground truth, network creation was carried out. Whereas previously, 4 
network combinations were carried out (2² due to 2 datasets being used), 9 network 
combinations were used for this network creation (3² due to 3 dataset being used 
(Cardiff + Cambridge combined equates to the 3rd dataset)). This was possible due to 
the Cardiff and Cambridge datasets being combined to form 1 larger dataset. This 
allowed for a greater quantity of ground truth images to be used in the training and 
validation of cellular images and thus led to greater accuracy levels.  
The ’DeepFlow’ neural network was used to generate the 9 network combinations. 
The most accurate overall network was Network D at 93.6% (Table. 5). Network C 
produced the greatest accuracy levels for both mononucleated cells (98.6%) and 
binucleated cells (97.7%) (Table. 5). Network D also produced the highest 
binucleated MN cell accuracy (89%) (Table. 5). Network A gave the greatest 
accuracy level to mononucleated MN cells (77.3%)(Table. 5).  
When evaluating overall accuracy, it could be shown that the overall accuracy of the 
networks peaked after the initial Cardiff dataset was amended with Network 1 
showing the highest accuracy levels out of all networks produced (93.8%) (Table. 4). 
However, this accuracy level only dropped by 0.2% in Network D to 93.6%, whereas 
binucleated MN accuracy increased from 71.8% to 89%, therefore justifying the 
minute decrease in overall accuracy (Table.4, Table. 5). There was also an increase 
in accuracy from the most accurate binucleated MN cell network pre-Cambridge 
dataset update, Network 2 with an 86.5% accuracy, to 89% accuracy in Network D 
(Table. 4, Table. 5).  
Network D, was a network trained using the Cardiff ground truth, validated using the 
Cambridge ground truth and accuracy levels were shown to be positively affected by 
updating the ground truth when compared to Network 5, which was trained and 
validated using the same datasets; but pre-Cambridge ground truth update. In 
Network D, there was a 0.1% decrease in overall cell accuracy and a 0.6% decrease 
in binucleated cell accuracy (Table. 5). However, there was also a 7.1% increase in 
binucleated MN cell accuracy, which is integral to the use of the network in MN 
analysis (Table. 5 When combining binucleated cells and binucleated MN cells 
together into an accuracy score out of 200 (Maximum 100% for Binucleated Cell 
accuracy and 100% for Binucleated MN accuracy), Network 5 scored 180.9, an 
average of 90.45% (Table. 4). This grouped percentage was 187.4%, an average of 
93.7% for Network D (Table. 5). There was also an increase in accuracy levels in 
mononucleated cells, up from 95.9% to 97.4%, and in mononucleated MN cell 
accuracy, up from 67.9% to 72.6% (Table. 4, Table. 5). Therefore, by using the 
training on Cardiff, validating on Cambridge networks, an increase was shown in the 
cellular accuracies of the cellular categories most important for MN analysis.  
When evaluating mononucleated and mononucleated MN cellular accuracies, 
increases were shown post-Cambridge update also. The previous highest 
mononucleated cell accuracy was shown in Network 1 at 96.9%, with Network 5 
showing the previous highest 2 channel mononucleated cell accuracy level at 95.9% 
(Table. 4). These levels were increased by 0.8% and 1.8% respectively to 97.7% in 
Network C (Table. 5). The previously highest rated mononucleated MN cell accuracy 
was Network 9 at 72.4%, produced in the 3-channel approach, and 71.4% shown in 
the 3-channel approach produced by Network 2 (Table. 4). An increase of 4.9% and 
5.9% was shown to generate the 77.3% accuracy level shown in Network A (Table. 
5). Interestingly, the most accurate network for mononucleated MN cells in all the 
network analysis was trained using a combination of the Cambridge and Cardiff 
ground truth, Network A (Table. 5). This allows for a greater quantity of images to 
be used to determine the cellular categories each cellular image should be placed in.  
It must be noted however, the most accurate network for binucleated MN cells, 
Network D was trained on just one dataset, the Cardiff ground truth and validated on 
only the Cambridge ground truth (Table. 5). A simple explanation could have been 
that the differences, however negligible they appear, between the nuclear stains used 
in the Cardiff and Cambridge ground truths (Draq5 vs Hoescht 33342) may have 
accounted for some confusion when training the network using the combined ground 
truth. However, the mononucleated MN cell category thrived on using the ground 
truth combination approach, therefore the difference in nuclear stains appears to have 
a negligible effect. Network H produced the highest accuracy levels for binucleated 
MN cell accuracy from the pool of combined ground truth networks, with an 84.5% 
accuracy shown (Table. 5). However, when viewing the mononucleated MN cell 
accuracy, it was only 53.6% accurate (Table. 5). An explanation for this may be the 
confusion of the network in confusing mononucleated MN cells as 
mononucleated/binucleated cells, given the slight drop shown in both mononucleated 
and binucleated cells when compared to the singularly trained Network D (1.5% in 
binucleated cells and 2% in mononucleated cells (Table. 5). This may seem an 
insignificant decrease, but Fig. 11 shows 211 mononucleated MN cells were scored 
initially, an accuracy level of 53.6% denoting 98 of the 211 mononucleated MN cells 
were mis-categorised. Thus showing how a potential difference in nuclear stains 
could have caused the neural network to mis-categorise a selection of mononucleated 
MN and possibly binucleated MN cells and therefore explaining why the combined 
ground truth did not necessarily produce the most accurate networks.  
In conclusion, owing to the nature of the MN assay, which can be carried out with 
and without cytochalasin-B and thus assessing binucleated or mononucleated MN 
cells, the most accurate network for each cellular category was researched, analysed 
and compared for use in dose response analysis. Thus, Network D was used going 
forward in the cytochalasin-B MN assay due to the highest binucleated MN cell 
accuracy level (89%) and highest combination of binucleated cell and binucleated 
MN cell accuracy (187.4) (Table. 5). Network A was thus chosen for the non-
cytochalasin-B MN assay due to the highest mononucleated MN cell accuracy 
(77.3%) and highest combination of mononucleated cell and mononucleated MN cell 






ix) Dose response analysis 
 
To fully evaluate the neural network approach and accuracy to analysis in the MN 
assay, a dose response was carried out using Carbendazim dosed on TK6 cells with 
cyto-B in a GSK laboratory and analysed using a variety of networks to showcase the 
accuracy of the neural network approach (Fig. 14). Manual scoring of the cellular 
images produced from the imaging flow cytometer were also analysed to form a 
comparison of neural network accuracy to a method comparable to the ‘gold 
standard’ of manual light microscopy (Verma et al., 2017). The background levels of 
MN testing are between 0.32%-1.38% (Lovell et al., 2018). Therefore, the 
background levels were evaluated using both the manual scoring of images approach 
and neural network also. It is of note that the Swansea historical lab background 
levels for MN rate in TK6 cells is 0.9%, which sits in between the historical 0.32%-
1.38%. The background manual scoring levels shown were 0.72% (Fig. 14), which 
sits in between the historical figures and slightly lower than the Swansea historical 
value. This can be explained, due to the dosing taking place in the GSK laboratory 
and thus more variables existing involved in determining the change in background 
MN levels. The most accurate Swansea Network (‘NETWORK D’ Table. 5), had 
background MN levels of 0.66% (Fig. 14), which is slightly lower than the manual 
scoring average but sits in between the historical MN rates of 0.32%-1.38% (Lovell 
et al., 2018). This shows the potential for neural network use in MN analysis and the 
ability of the network to accurately score background MN levels in different 


















a) i) Stats 
 
When assessing the normality of the GSK dataset and the MN distribution between 
replicates, the Shaprio-Wilks test showed that all the networks used in the GSK dose 
response testing (Fig. 14) had a P value of >0.05 and therefore the data was normally 
distributed.  
When carrying out the Dunnett’s test, each of the three doses used, 0.8μg/ml, 
1.2μg/ml and 1.6μg/ml, showed a significant increase when compared to the control. 
Therefore, the lowest observed effect level (LOEL) was the 0.8μg/ml dose of 
Carbendazim. Since only three doses were carried out in the dose response analysis 
for the GSK dataset, a determination could not be made on the 0.4μg/ml dose which 
was used in the Newcastle and Cardiff analysis (Fig. 15).  
To calculate the network with the greatest accuracy in respect to the manual scoring 
of cellular images, a variation distribution was taken. Comparing the spread of 
ranges and variation distribution between each network and the ‘control’ of manually 
scored cells. The spread of: range, standard deviation, standard error and coefficient 
of variation were all analysed and interpreted to understand which network provided 
the greatest results in practical terms when used in the dose response setting, for 
which they were created for. Therefore, it is important to note, that despite specific 
networks showing higher accuracy levels, these accuracy levels were not always 
translated into he dose response shown when compared to the manually scored 
images, which in this case is the ‘gold standard’ (Verma et al., 2017). The variations 
between network results and manually scored images was compared to the variation 
and range levels shown when just assessing the manually scored images, to gage 
values to form a comparison based on.  
The Newcastle dataset focused on assessing mononucleated cells with a MN to carry 
out a dose response, due to the lack of cytochalasin-B. Four doses were used in the 
dose response, a control, 0.4μg/ml, 0.8μg/ml, 1.2μg/ml and 1.6μg/ml (Fig. 20). Thus, 
similar doses were used in comparison to the GSK dose response, with the extra 
addition of the lower 0.4μg/ml dose. The same doses were used in Cardiff analysis of 
the dose response also and therefore allowed for a direct comparison to be made 
between the Cardiff and Newcastle datasets. In the Newcastle dose response, the data 
was once again found to be normalised and therefore a Dunnett’s test could once 
again be carried out. Interestingly, since a lower dose was added, the 0.4μg/ml, it was 
found that a significant increase in MN frequency was not found for this dose. 
Therefore, the no observed effect level (NOEL) for the Newcastle dataset was 
0.8μg/ml and the LOEL was 1.0μg/ml (Fig. 15, Fig. 16).  
 
ii) Further Dose response analysis 
 
A dose response was carried out on the Cardiff network to assess network 
reproducibility across different laboratories. By assessing the dose response of 
Carbendazim on mononucleated cells, a comparison was made between the 
Newcastle and Cardiff networks using the same chemical (Carbendazim), same cell 
type (mononucleated cells, no cytochalasin-B used) and using the same neural 
network (Table. 5, Network A).  
When assessing the range and coefficient of variations found when comparing the 
mean of the Cardiff and Newcastle non-cyto-B Carbendazim samples, a cumulative 
36.73% coefficient of variation was shown. This figure was lower than any 
previously carried out in the GSK data analysis, where the lowest coefficient of 
variation shown was 50.19%, which was used in comparing all the values of the most 
up to date network and the manual scoring approach. Considering the coefficient of 
variation was 52.92% when comparing the values of the manual scoring triplicates, 
great confidence can be taken from the 36.73% variation of coefficient value 
produced in the dose response comparison of the mean values shown following 
analysis of the Cardiff and Newcastle laboratories. Moreover, the figure can be 
further examined to show a 0.66% and 3.04% coefficient of variations produced for 
the middle two doses of 0.8μg/ml and 1.0μg/ml in the comparison of Cardiff and 
Newcastle networks, showing large degrees of similarity, gaining confidence in the 
application of the same neural network into multiple datasets.  
Therefore, the production of dose responses across three laboratories (GSK, Cardiff 
and Newcastle) provided the basis for the reproducibility of using a ground truth 
based neural network to assess dose responses across different laboratories and using 
the same neural network. All three networks focused on the use of TK6 cells treated 
with Carbendazim with/without the presence of Cytochalasin-B and all three 
networks showed a significant increase in MN frequency at higher doses, in line with 
expected results. This shows a proof of concept study into the use of deep learning, 
ground truth based neural networks in the dose response setting of the MN assay and 
the potential to revolutionise this assay by streamlining the procedure, whilst 











b) Assessment of MCL-5 and AHH-1 populations 
 
The neural networks produced were used in the assessment of MCL-5 and AHH-1 
populations to identify the far-reaching uses of the network. Network ‘A’ was used 
to determine the background levels of MN due to the MCL-5 and AHH-1 cells being 
cultured without the use of cytochalasin-B and thus mononucleated cells and 
mononucleated MN cells were used in the determination of MN frequency. 
Therefore, Network ‘A’, with an accuracy of 77.3%, was used in the analysis. A 
background rate of 0.74% was observed in the AHH-1 cells and 0.66% in the MCL-5 
cells (Figure. 22). This is consistent with the background rate of MN in literature as it 
is between 0.32% and 1.38% (Lovell et al., 2018). However, this is lower than the 
historical background MN levels in our lab, which sit at 1.3% for AHH-1 cells and 
1.48% for MCL-5 cells. This is an almost exact doubling of the results shown by 
Network ‘A’. There are multiple reasons for this being the case. MCL-5 ad AHH-1 
cells are not the same size as TK6 cells, this is highlighted when using a coulter 
counter to measure the quantity of cells in a sample, 5-17μm is used as standard for 
MCL-5 cells, whereas TK-6 cells are 10-17μm. The difference in size may account 
for the lower rates shown compared to the norm. With the training and test data 
comprising of different sized cells and thus adding to the confusion. However, it 
must be noted, that despite the background levels being lower than the historical 
average for our Swansea lab, the results still sit within the norm of 0.32-1.38% 
(Lovell et al., 2018). 
When O6-BG was added to the MCL-5 cell line respectively, a major MN frequency 
increase was shown from 0.66% to 1.92% (Figure. 18). This is somewhat 
unsurprising, given the role of O6-BG in preventing DNA repair via MGMT (Estellar 
et al., 1999). Despite this being the control sample and exogenous damage not being 
present, endogenous damage does still take place in the cell lines and by adding O6-
BG and inhibiting DNA repair, some of this endogenous damage remains un-
repaired and gives rise to chromosomal damage in the form of breaks and addition 
which presents itself as MN (Ochs and Kaina, 2000). Therefore, there is an increase 
in MN frequency shown in Fig. 18. Moreover, the MCL-5 cell line contains 5 
cytochromes p450s, including CYP1A1, this allows for greater levels of metabolic 
activity, which can heighten DNA damage via metabolising endogenous sources at a 
far greater rate (Crofton-Sleigh et al., 1993). It is the metabolic products which tend 
to cause DNA damage rather than the original source itself. More work is needed on 
the application of neural networks to MCL-5 and AHH-1 dosing. This initial work 
shows the potential to use the neural network to test background levels in these cell 
lines, a full dose response using MCL-5 and AHH-1 cell lines would be the next step 
and a comparison to be made to the TK-6 dose response evaluated here, in both 
samples with and without cytochalasin-B. There would also be the potential to create 
a ground truth using the MCL-5 and AHH-1 networks and to assess how this affects 





x) GSK ground truth population 
 
Following the manual scoring of the GSK dataset, in order to provide a comparison 
to the automated neural network approach, each individual cell was attributed a 
cellular phenotype in accordance with the categories used in the ground truth. 
Despite this being carried out as a comparison and to calculate the replicative index 
(RI), the result was the annotation of 25,805 cellular images (Fig. 12).  
This data has the potential to be used in future neural network analysis as a 3rd 
dataset, once the word document containing the phenotypes of the cellular categories 
has been applied to a set of code. This allows for MatLab® to differentiate the 
images into their separate categories and to use as a ground truth. This has the 
possibility to further increase the robustness of the neural network approach. By 
applying a third dataset, there can be a greater volume of cellular images of the rarer 
phenotypes, especially the ‘Mononucleated MN cells’ and ‘Binucleated MN’ cells, 
which are of great interest in dose response analysis. By adding a third dataset, a 
larger quantity of MN images will be obtained overall, allowing for a further increase 
in ‘Mononucleated’ and ‘Binucleated MN cell’ accuracy. This is of particular interest 
in the ‘Mononucleated MN’ cell category, where the greatest dose response produced 









In conclusion, a clear comparison was shown between the deep learning approach to 
the automation of the in vitro MN assay and the manual assessment of cellular 
images for carrying out the in vitro MN assay with cyto-B, shown using the 
assessment of Carbendazim and compared to manual scoring approaches and the 
historical gold standard (Verma et al., 2017). 
The GSK cyto-B dose response showed a clear comparison between automated and 
manual scoring approaches, showing that the integrity of the assessment had not been 
compromised in the streamlining of the scoring approach. The results were 
comparable when using the deep learning neural network for assessment, despite the 
process being far less laborious and time consuming than the gold standard of 
manual scoring using light microscopy (Fenech, 2000).  
The neural network was clearly developed, resulting in a model with peak accuracy 
levels achieved and showing an 89% accuracy on Binucleated MN cells despite only 
training from a ground truth population of 155 Binucleated MN cells. It is no small 
feat to achieve accuracy levels this high using this little quantity of ground truth 
images. Moreover, the applicability of the network was shown using the Cardiff and 
Newcastle datasets, whereby dose response results were found to be comparable to 
one another. This streamlines the process even further, as it allows the user to use a 
pre-created ground truth and therefore network to analyse samples. The 
reproducibility of the dose responses across the three laboratories shown, shows 
great promise for this technique in the future. More chemicals are required to be 
testing, outside the scope of Carbendazim, to allow this method to be used on a wider 
scale. Moreover, a dataset comprising of manually scoring a non cyto-B MN assay 
could be carried out in the future to provide a direct comparison when carrying out 
the assessment of mononucleated and mononucleated with MN cells. 
It is thought that aneugens and clastogens produce slightly different shaped MN, this 
can therefore prove a potential stumbling block in the application of the ground truth 
to other datasets. However, the Cardiff network was trained using a mixture of 
aneugens and clastogens and therefore one would expect dose response accuracy 
levels to be maintained following the assessment of clastogens also.  
Initial studies were carried out on MCL-5 and AHH-1 cells and showed great 
similarity to one another and potential for this cell line to be assessed using a ground 
truth formed entirely of TK-6 cells. This would once again streamline the method 
further, as the creation of a separate ground truth to assess MCL-5 and AHH-1 cells 
may not be required. This could be a huge addition, as MCL-5 and AHH-1 cells are 
commonly used in the assessment of genotoxic and carcinogenic compounds 
requiring metabolic activation, such as NDMA. Therefore, an interesting future study 
can be centred around the assessment of NDMA and other nitrosamines using this 
deep learning neural network approach and to determine the use of this method in 
producing a dose response to MCL-5 and AHH-1 cell lines using different chemical 
compounds.  
 
More future work could be carried out in carrying out a manually scored dose 
response triplicate for the non cyto-B MN assay as mentioned previously, which 
would allow for a direct comparison between the automated deep earning assessment 
of mononucleated cells and mononucleated MN cells in determining a dose response. 
In this study, the non cyto-B results were compared to other laboratories results and 
then again to the historical background figures to determine correlation to the ‘gold 
standard’. However, carrying out a manually scored comparison of such 
mononucleated and mononucleated with MN cells would be something to consider 
yet.  
Moreover, forming greater ground truth populations, as this would lead to the 
increase in the rarer cellular types, such as MN, and allow for a further increase in 
neural network accuracy. The greatest Mononucleated MN cell accuracy was 77.3%, 
showing plenty of room for the improvement of the accuracy. This was highlighted 
in the Newcastle and Cardiff dose responses, whereby only the top Cardiff dose was 
found to have a statistically significant dose response to the control sample and only 
the top doses were found to have a statistically significant dose response in the 
Newcastle dataset. The dose responses recorded were slightly lower than the 
historical MN average for Carbendazim in the non-cytochalasin-B MN assay and 
were also shown too be far lower than the values found in the GSK cytochalasin-B 
dose response. Therefore, the Mononucleated MN cell accuracy can be attributed to 
part of the reason for the reduction in dose response, suggesting that in this case, the 
Mononucleated MN accuracy levels were not high enough and therefore too specific 
in this case in the analysis of cellular phenotypes. By adding more ground truth 
images, it would be possible to allow for a greater quantity of Mononucleated MN 
cells to be manually assessed and then used in the training for a neural network.  
The addition therefore of the GSK ground truth to future neural network assessments 
should allow for an increase to be shown in all cellular categories, but especially 
Mononucleated MN cell accuracy. This GSK ground truth, which I manually scored 
when forming a comparison to  the automated accuracy of Network A, has the 
potential to further increase the accuracy, specificity and sensitivity of this method in 
the in vitro  MN assay assessment.  
 
The deep learning neural network approach, a novel approach in this research setting, 
was therefore shown to produce a dose response following Carbendazim treatment. 
This dose response was shown to be comparable to the manual scoring of cellular 
images produced following imaging flow cytometry processing (a comparable 
method to the gold standard of manual light microscopy assessment).  
By definition therefore, this approach is comparable with the gold standard and 
maintains the integrity of the results, whilst streamlining the method and the time 









Confusion matrices and neural network formation provided in addition to the training with 
Cardiff, validating with Cardiff (Fig. 13) which is provided in the main text under results. The 
following datasets are included here: 1) Training with Cardiff, validating with Cambridge 
(Fig. 20), 2) Training with Cambridge, validating with Cardiff (Fig. 21) and 3) Training with 







































Figure. 20 Confusion matrices produced post neural network creation using MatLab®. 
Training on the ‘Cardiff’ dataset and validation on the ‘Cambridge’ data set. Overall 
accuracies shown as well as accuracies per individual subgroups.  
III 
A) Neural network formed after using the initial ground truth population and a 3-channel approach 
of: Brightfield, Fluorescence, Fluorescence. Network 3 produced this confusion matrix. 
B) Neural network formed after using the first updated ground truth and using a 3-channel approach 
of Brightfield, Fluorescence, Fluorescence, Network 4 produced this confusion matrix.  
C) Neural network formed after using the first updated ground truth and the 2-channel approach of: 
Brightfield and Fluorescence. Network 5 produced this confusion matrix.  
D) i) Neural network formed post Cardiff and Cambridge ground truth updates and the 2-channel 
approach of: Brightfield and fluorescence (1, 11). Network D produced this network 
    ii) Figure showing the training development of Network D up to 20 epochs. Accuracy and error rate 
are both shown. 
                  iii) The results section after completing a network run, showing the accuracy rate of the         
network produced after completing 20 epoch cycles, other key statistics are also shown, such as 










































Figure. 21. Confusion matrices produced post neural network creation using MatLab®. 
Training on the ‘Cambridgef’ dataset and validation on the ‘Cardiff’ data set. Overall 
accuracies shown as well as accuracies per individual subgroups.  
III 
A) Neural network formed after using the first updated ground truth and using a 3-channel approach 
of Brightfield, Fluorescence, Fluorescence, Network 6 produced this confusion matrix.  
B) Neural network formed after using the first updated ground truth and the 2-channel approach of: 
Brightfield and Fluorescence. Network 7 produced this confusion matrix.  
C) i) Neural network formed post Cardiff and Cambridge ground truth updates and the 2-channel 
approach of: Brightfield and fluorescence (1, 11). Network E produced this network 
    ii) Figure showing the training development of Network E up to 20 epochs. Accuracy and error rate 
are both shown. 
iii) The results section after completing a network run, showing the accuracy rate of the         network 
produced after completing 20 epoch cycles, other key statistics are also shown, such as iterations 
































































Figure. 22 Confusion matrices produced post neural network creation using MatLab®. 
Training on the ‘Cambridge’ dataset and validation also on the ‘Cambridge’ data set. Overall 
accuracies shown as well as accuracies per individual subgroups.  
A) Neural network formed after using the initial ground truth population and a 3-channel approach 
of: Brightfield, Fluorescence, Fluorescence. Network 8 produced this confusion matrix. 
B) Neural network formed after using the first updated ground truth and using a 3-channel approach 
of Brightfield, Fluorescence, Fluorescence, Network 9 produced this confusion matrix.  
C) Neural network formed after using the first updated ground truth and the 2-channel approach of: 
Brightfield and Fluorescence. Network 10 produced this confusion matrix.  
D) i) Neural network formed post Cardiff and Cambridge ground truth updates and the 2-channel 
approach of: Brightfield and fluorescence (1, 11). Network F produced this network 
    ii) Figure showing the training development of Network E up to 20 epochs. Accuracy and error rate 
are both shown. 
The results section after completing a network run, showing the accuracy rate of the         network 
produced after completing 20 epoch cycles, other key statistics are also shown, such as iterations 

























Adobe Bridge®: Software commonly used by photographers which allows for the 
ground truth to be created in this case and cellular images analysed on an individual 
basis and grouped accordingly.  
Batch size: the quantity of samples which will be put through the system at a time 
Carbendazim: An aneugenic agent commonly used in dose response analysis due to 
its well-studied mode of action. 
Confusion Matrix: A figure produced after assessing a Neural Network on a dataset. 
Accuracy levels are shown so that the user can relay the information going forwards 
on what category/categories require improvement. Normally produced when 
attempting to increase the accuracy of the network or when carrying out a dose 
response.  
Cytochalasin-B: A spindle poison commonly used in the MN assay as it disrupts 
cytokinesis and therefore not allowing the cells to divide their cytoplasms, whilst 
nuclear division continues, giving the cells their binucleated cell appearance.  
Deep Learning: An artificial intelligence approach which mimics the workings of a 
human brain by using neural networks to recognise patterns from training data sets.  
Epoch: A complete training cycle on an entire data size. Shown during the neural 
network creation, optimal level required. Too high an epoch frequency can lead to 
the error rate increasing. Too low an epoch accuracy can cause the epoch count to 
not reach optimal accuracy levels. 
Ground truth: A set of images which have been manually assessed by the user and 
confirmed to be displaying a specific phenotype or shape required. The Network is 




Imaging Flow Cytometry: A machine used which carries out analysis on samples 
by suspending samples in fluid and analysed by the machine following excitation of 
fluorescent markers by light, causing the light to be scattered and high throughput 
analysis to be undertaken. The imaging flow cytometer allows the user to click on 
individual cellular images for analysis and provides extra confidence into the results 
and added sample integrity.  
 Micronucleus: A smaller than normal nuclei, 1/3rd to 1/16th the diameter of a 
regular nucleus. Occur at a resting level in healthy cells, but levels are elevated 
following exposure to agents causing chromosomal damage and this can be used to 
calculate a dose response using the MN assay. 
Neural Network: A series of algorithms linked to one another, much how neurones 
are in the brain, working in tandem to recognise patterns and efficiently analyse data.  
Training Set: The Ground Truth dataset used in order to teach the neural network 
how to identify a specific pattern. 
Validation Set: The images used to assess the Neural Network based on what the 
training set has taught it. This should not be the same as the training set as can result 
in false positives. If using the same dataset for training and validation, then split this 
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